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ABSTRACT

ACUTE PAIN SYMPTOM ASSESSMENT
IN NONVERBAL PUERTORICAN PATIENTS IN THE EARLY
POSTOPERATIVE PERIOD
September 2016
SHERILY PEREIRA, BSN, PONTIFICAL CATHOLIC UNIVERSITY OF PR
MSNA, UPR MEDICAL SCIENCES CAMPUS
PH.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Annette Wysocki

Acute pain is a symptom that represents significant concern for surgical patients
during the early postoperative period. This is probably due to the use of ineffective
instruments or protocols for assessment in patients with different levels of sedation after
general anesthesia. This study described the relationships between the total scores obtained
from two pain assessment instruments, the Non-verbal Pain Scale Revised (NVPS-R) and
Critical Care Pain Observation Tool (CPOT), during the early postoperative period for nonverbal patients at Post Anesthesia Care Unit (PACU). After assessing patient’s pain with
both instruments simultaneously, we determined, and evaluated the relationships between
the two behavioral instruments to assess acute pain in the early postoperative period.
Recent literature confirmed the research gap in assessment of postoperative pain in
nonverbal patients due to inadequate evidence to guide recommendations about which
specific non-verbal pain instrument to use. The results of this study present a high
correlation between total pain scores of both behavioral assessment instruments, CPOT and
NVPS-R, for postoperative patients after abdomino-pelvic, gastrointestinal and
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gynecological surgeries. Incidental findings suggest that CPOT vocalization indicator was
consistently present in patients with significant pain. Increases in the NVPS-R vital signs
and respiratory indicators were not seen consistently in patients with significant pain. The
vital sign indicators included in the NVPS-R need to be further investigated to determine
their validity for assuring pain assessment because our findings do not support their use
exclusively. Physiologic indicators as heart rate, mean arterial pressure, respiratory rate and
pulse oxygen saturation were not good indicators of acute pain. This study is important
because pain assessment is the best way to initiate the most appropriate treatment to
alleviate pain after surgery. Institutions where surgeries are performed need to standardize
and provide clear policies and procedures for effective postoperative pain assessment and
management. Healthcare providers are patient advocates and a clear vision in providing the
most effective management contributes to decrease the worldwide problem of
undertreatment of acute pain.
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CHAPTER 1
INTRODUCTION
Statement of the Problem
The National Institutes of Health has identified improved treatment of pain as a priority:
“the experience of pain and the challenge of treatment have remained uniquely individual and
unsolved” (U.S. DHHS, 2006). In 2010, the Joint Commission on Accreditation of Healthcare
Organizations released the National Patient Safety Goals (NPSG) prioritizing pain management
as a standard of care. The NPSG standards require organizations to acknowledge the rights of
patients in order to assess and manage pain appropriately, screen patients for pain, and educate
patients suffering from pain and their families (JCAHO, 2010). Acute pain is a common
symptom after surgery and one of the most important postoperative physiological recovery
domains (Lindqvist, Royse, Brattwall, Warrén-Stomberg, & Jakobsson, 2013). According to the
National Center of Health Statistics (2010), the total number of inpatient surgical procedures was
51.4 million. After surgical procedures, acute pain is between moderate to severe. Data suggest
80% of patients experience pain postoperatively, with between 11-20% experiencing severe pain
(Apfelbaum, Chen, Mehta, et al., 2003).
Despite the availability of analgesics and national guidelines to manage pain, the
incidence of postoperative pain has remained stable over decades (Hutchinson, 2007). Acute pain
associated with surgical procedures is common in the early postoperative period and remains
inadequately assessed and managed. This is probably due to the use of ineffective instruments or
protocols for pain assessment in patients under sedation due to general anesthesia. An extensive
literature review identified a gap in the assessment and management of acute pain in the early
postoperative period. This points to the need for an instrument that assesses acute pain in the
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early postoperative period for patients with levels of sedation after general anesthesia and to
establish a standard of care.
Definitions of pain have been refined to include the fact that a person's inability to
verbally communicate does not preclude the possibility that pain is present or negate the
responsibility of healthcare providers to treat it. Currently, post anesthesia care unit (PACU)
nurses do not use an effective instrument for the assessment of acute pain in non-verbal adult
patients after general anesthesia. During the early postoperative period a patient’s state of
consciousness changes from an unconscious level to wakefulness. The patient’s level of
consciousness should be considered when pain assessment is performed in this population.
The use of valid and reliable pain measurement instruments while patients are still under
sedation in the PACU would lead to earlier and better pain assessment and management and a
significant decrease in postoperative complications. The effects of unrelieved acute pain can
have a significant impact on a patient’s recovery from surgery and general anesthesia. Inadequate
pain assessment and management have been linked to increased morbidity and mortality
(Shannon & Bucknall, 2003). Poor treatment of acute pain may lead to the development of
serious complications (Dunwoody et al., 2008), which can impact a patient’s physical
functioning, satisfaction, and well being after surgical procedures. In postoperative patients,
functional goals include deep breathing, ambulating, and being able to participate in physical
therapy (Carr & Goudas, 1999) and acute pain directly impacts those goals.
Background and Significance
Literature suggests that unrelieved pain can contribute to the development of several
multisystem effects. These effects include an increase in physiological parameters such as heart
rate and blood pressure (Payen, Bru, Bosson, Lagrasta, Novel, & Deschaux, 2001; Stotts et al.,
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2004), atelectasis (Puntillo & Weiss, 1994), blood clots, pneumonia, vasoconstriction, decreased
tissue-oxygen partial pressure (Akca et al., 1999), hyper-metabolism resulting in hyperglycemia,
delay in wound healing and risks of wound infection (McGuire, Heffner, Glaser, Needleman,
Malarkey, & Dickinson, 2006). These multisystem effects adversely affect postoperative
outcomes.
Continuous post-operative assessment and management of pain by nurses is of utmost
importance because it guides them in the process of providing analgesia before patients reach a
maximum acute pain threshold. The postoperative pain management guideline and the pain,
agitation, and delirium (PAD) guideline, both recommend providing continuous assessment of
patient’s pain (Bader et al. 2010; Barr, Fraser, Puntillo, Wesley, Gélinas, Dasta, 2013) to achieve
early recognition and early treatment. Adequate acute pain assessment would help nurses
identify objective measures for the development of new effective protocols for better acute pain
management.
Current literature is directed at the use of different verbal pain scales during the
postoperative period. However they have not been recommended for non-verbal patients in the
PACU due to the lack of research in this area. In 2016, the American Pain Society, along with
the American Society of Anesthesiologists, commissioned an interdisciplinary expert panel to
develop a clinical practice guideline to promote evidence-based, effective, and safer
postoperative pain management. The recommendations were based on the underlying premise
that optimal management begins in the preoperative period to develop a plan of care tailored to
the individual and the surgical procedure involved, and extends to the continuous pain
assessment of the patient (Chou et al., 2016).
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The most consistently used pain scales in the PACU are subdivided in three categories for
pain assessment. The categories include 1) verbal pain scales, 2) multidimensional pain scales,
and 3) behavioral pain scales. The verbal pain scales assess pain intensity while
multidimensional pain scales assess the quality of pain. Both of these categories of scales require
a patient’s verbal self-report. Consequently, patients need to be able to verbally communicate for
these assessments to be useful. The last category of scales is the behavioral pain scales. These
instruments assess pain through a framework that usually consists of physiological changes,
body language and behavioral changes (Stites, 2013)
Two previously validated behavioral pain scales for use in PACU were designed
specifically to measure behaviors for patients with cognitive impairment and dementia, and both
are for older adults (Kovach, Weissman, Griffie, Matson, & Muchka, 1999). Other types of
behavioral pain scales used to assess acute pain in critical care units are the behavioral pain scale
(BPS), the Critical Care Pain Observation Tool (CPOT), and the revised Nonverbal Pain Scale
(NVPS-R). The limitation in the application of the BPS for acute pain assessment is the
requirement for a level of consciousness because this instrument is limited to intubated
patients (Barr et al., 2013). An adaptation of the BPS was designed for non-intubated critically ill
patients (BPS-NI) (Chanques et al., 2009). However, the BPS- NI instrument needs more
research to validate its psychometric properties.
So far, of the available observational pain scales, the CPOT has shown superior reliability
and validity when used in nonverbal critically ill adults (Stites, 2013). The CPOT effectively
measures acute pain in sedated non-intubated patients, but needs more research, as it has not
been studied in PACU patients. NVPS-R contains behavioral dimensions and physiological
dimensions that are graded in severity. Some authors concluded that the NVPS-R was a valid
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observational pain scale (Stites, 2013), however a comparison between CPOT and NVPS-R in
sedated patients at early postoperative period, has never been studied.
After reviewing the applicability of these nonverbal pain assessment instruments in
patients under levels of sedation after general anesthesia, a recommended one cannot be found.
The available instruments were designed and validated for used with conscious patients and
other behavioral scales for those patients with cognitive impairment. Thus, there is a need for a
pain assessment instrument for patients under sedation in the early postoperative period, which
would aid in the early identification and anticipatory relief of pain.
The early postoperative period is the time immediately after the patient arrives at the
PACU and extends for approximately two hours. During this early postoperative period,
significant pain from surgical procedure is expected and acute pain can sometimes be difficult to
assess because residual effects of general anesthesia are particularly high.
The most commonly used instrument for the assessment of acute pain in the PACU is the
self-reported Numeric Rating Scale (NRS), which is considered the gold standard for the
assessment of pain (Li, Puntillo, Miaskowski, 2008). However, the NRS instrument was
designed and validated to evaluate pain intensity in verbal, conscious patients and is not an
adequate instrument to evaluate patients unable to self-report their pain. The sole use in the
PACU of the NRS for the assessment of acute pain can delay early assessment, which can lead to
a poor pain management. Pain assessment using appropriate instruments to measure pain in nonverbal adult patients under sedation is currently not a standard protocol in PACU’s in Puerto
Rico and other countries.
Nurses routinely begin the assessment of acute postoperative pain when patients are able
to report pain verbally. The delay of acute pain assessment is significant in nonverbal patients
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because it leads to an increase in the time that the patient needs to recover physiologically and
psychologically to attain their health status. This delay increases the risk for postoperative
complications, the length of patient’s stay in the PACU, and in the hospital, and medical costs.
The American Society for Pain Management Nursing (ASPMN), the American Pain
Society (APS), the American Society of Anesthesiologists (ASA), and the Centers for Disease
Control and Prevention, all emphasize the importance of pain assessment for better pain
management. The recommendation for pain assessment is the use of the most valid and reliable
behavioral pain scales for monitoring pain in medical, postoperative, or trauma settings. Because
adult intensive care unit (ICU) patients are sometimes unable to self-report pain, the use of valid
and reliable bedside assessment instruments continues to be an important part of pain
management. The ability to reliably assess a patient’s pain is the foundation of effective pain
treatment (Barr et al., 2013).
Pain assessment is essential for appropriate treatment, especially as part of a
comprehensive pain management protocol. The PAD and management of postoperative pain
guidelines presents two behavioral pain assessment instruments as the most valid and reliable
scales, the BPS and CPOT. Those instruments have been validated for monitoring pain in
medical, postoperative, and trauma ICU patients. The quality of evidence is moderate (Barr et
al., 2013; Chou et al., 2016) showing the need for more research, especially during the
postoperative period. The use of the CPOT during the early post-operative period in patients
after general anesthesia under levels of sedation has never been studied.
A systematic review that tested pain assessment instruments for use with sedated patients
states that the CPOT may also prove to be useful in assessing pain among sedated patients (Cade,
2008). During the nociceptive exposure of postoperative cardiac patients, the CPOT had a
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sensitivity of 86%, a specificity of 78% and was effective for the screening of pain. The CPOT
seems to be a useful instrument to detect pain in intubated postoperative cardiac adults,
especially during nociceptive procedures (Gélinas, 2009). However, to date no specific
nonverbal pain assessment instrument has emerged that is superior to other instruments and has
been tested for reliability and validity in nonverbal patients after surgery.
To facilitate the effectiveness of acute pain management after surgery and general
anesthesia there is a need to establish clear protocols and a systematic routine including the most
effective measurement instruments for the assessment of acute pain in nonverbal patients under
sedation. The effective measurement instrument selection must include the initial evaluation of
the level of sedation of the patient to select the appropriate pain assessment instrument for verbal
and non-verbal patients. The use of the Richmond Agitation Sedation Scale (RASS) is necessary
to establish a patient’s level of sedation before using the CPOT. In patients at the deepest level
of sedation, the pain behaviors are decreased to -4 RASS (Li, Puntillo, & Miaskowski, 2008).
The CPOT could be a predictive measure of acute pain in patients under sedation, after general
anesthesia.
An early assessment during the postoperative period can promote pain relief, such that all
patients receive the most effective acute pain management following general anesthesia. The
advantage of this early intervention is the identification and management of pain before the
patient reaches an acute pain threshold.
Purpose of the study
This study assessed the relationship between the CPOT and the NVPS-R for acute pain
assessment in the early postoperative period after general anesthesia in sedated patients. The
specific purpose of this research study was to compare the use of two behavioral acute pain
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assessment instruments during the early postoperative period for non-verbal sedated patients to
enhance anticipatory assessment and management of pain. One behavioral instrument was the
adult NVPS-R, and the second was the CPOT behavioral pain scale. Both instruments were used
simultaneously, to determine and evaluate relationships between both nonverbal instruments to
assess acute pain in the early postoperative period for patients under sedation. Knowledge
derived from this research is expected to help in the development of protocols that would allow
for better pain identification and management during the early post-operative period.
The use of the behavioral instruments CPOT and NVPS-R in the PACU provides a new
alternative in the process of early acute pain assessment to improve post-operative acute pain
management. These research data could be useful for continuing education of nurses working in
the PACU to increase their knowledge of pain manifestations, pain assessment and pain
management. It is hoped that through this type of exploratory research, behavioral pain
assessment instruments can be used as part of a systematic routine during the early postoperative
period in the PACU to decrease omissions in effective acute pain assessment in patients under
sedation.
Theoretical Framework
The incidence of postoperative acute pain suggests that symptom management research
is a priority for adults. The symptom management theory (SMT) is a middle range theory
depicting symptom management as a multidimensional process (Linder, 2010). In Harver and
Mahler (1990), a symptom was defined as a subjective experience, reflecting changes in biopsycho-social functioning. Research addressing symptom management is recognized as a priority
(Berger, Cochrane, & Mitchell, 2009; Hockenberry, 2004).
The SMT model of the theory, illustrates a multidimensional process of symptom
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management. Three essential concepts include symptom experience, components of symptom
management strategies and outcomes. The concepts are framed within the dimensions of nursing
science: person, environment and health and illness, to serve as a reminder of the contextual
considerations of nursing research. The model provides a conceptual framework for
understanding relationships between factors influencing the symptom experience as well as the
larger contextual factors influencing symptom management. Additionally, the model includes the
patient’s role in self-care. With regards to postoperative acute pain in adult patients, it can guide
nursing interventions aimed at influencing the context in which intense acute pain is occurring as
well as the development of symptom management strategies. The goal is to eliminate the
symptom or minimize the distress of the symptom experience.
The method of this study was contained within the model as part of the component of
symptom management strategies, because it incorporates who, what, and how the strategies are
implemented. The early decrease in pain is the expected symptom status defined in the context of
outcome in the framework. The symptom management theory (SMT), guides pain symptom
assessment and treatment management in practice and research. The theory is applicable to a
variety of symptoms and patient populations in different settings and provides the perfect
framework to develop an improvement in acute pain assessment and management. The model of
the theory focused on three factors: the symptom experience, that is acute pain; symptom
management strategies, that is an early acute pain assessment; and outcome/symptom status,
which is acute pain early identification and/or pain relief (Figure 1).
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Figure 1. Symptom Management Theory Model application to the study
To achieve the proposed outcome of early identification of acute pain symptom and
hence, acute pain relief in postoperative patients, three factors were considered including
patient’s experience of acute pain symptom (behaviors, perception, and response of pain), type of
analgesia (medications and doses), and assessment and management strategies (assessment
instruments: CPOT, NVPS-R). To achieve acute pain relief, nurses need to use appropriate
assessment and management strategies and an important component for effective postoperative
acute pain management is early pain assessment. Patients, who receive general anesthesia during
surgery, arrive to the PACU under sedation; therefore pain behaviors could be decreased. If
nurses use appropriate instruments to assess pain before patients become conscious, early
management can be given to achieve acute pain relief. Early identification of acute pain is
extremely important for proper management, before patients achieve or exceed the maximum
acute pain threshold.
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Definition of Terms and Operational Definitions
1) Pain: an unpleasant sensory and emotional experience associated with actual (surgery) or
potential tissue damage or described in terms of such damage (International Association for the
Study of Pain, 1979).
2) Acute pain: is an expected physiologic experience to noxious stimuli (surgery) that can
become pathologic, is normally sudden in onset, time limited, and motivates behaviors to avoid
actual or potential tissue injuries. Pain that can be either brief, lasting moments or hours, or it can
be persistent, lasting weeks/several months until the disease or injury. The condition has a
predictable beginning, middle and end. For research purposes, acute significant pain is defined
by behavioral pain scales as CPOT > 3 and NVPS-R > 3.
3) PACU: post anesthesia care unit, also known as recovery room.
4) General Anesthesia: A drug-induced loss of consciousness during which patients are not
arousal, even by painful stimulation (ASA, 1999).
5) RASS: Richmond Agitation Sedation Scale is a measurement scale with values ranging from 5 to 4. Those values from -5 to -1 correspond to sedation, values of 0 to alert and calm, and 1 to
4 is agitation. For research purposes, RASS measure of sedation was between -4 to -2. Levels of
sedation are -4 = deep sedation, -3= moderate sedation, and -2 = light sedation.
6) Early Postoperative period: is the immediate postoperative period in the PACU. For the
purposes of this research study, the early post-operative period is the time period from 1 to 120
minutes after patient arrived from operating room (OR) to PACU.
7) Postoperative outcomes: patient satisfaction, decrease in medication consumption (opioids,
non-opioids), decrease in secondary effects (nauseas/vomitus), decrease in pain behaviors.
8) NVPS-R: Non-verbal pain scale. A behavioral pain instrument for the assessment of acute
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pain. Measures contain behavioral categories (facial expression, activity, and guarding) and
physiological categories (heart rate, blood pressure) and respiratory component (respiratory rate
and pulse oximetry). Items in each category are scored from 0 to 2 with a possible total score
ranging from 0 to 10 (Rochester, 2004). The revised version (NVPS-R) was used in this study.
9) CPOT: Critical Care Pain Observation Tool. Measures behaviors in non-verbal patients. It
includes four behavioral indicators: 1) facial expression, 2) body movements, 3) muscle tension,
and 4) compliance with the ventilator for intubated patients or vocalization for non-intubated
patients. For this study, the vocalization indicator was used because all participants were nonintubated patients. Items in each category are scored from 0 to 2 with a possible total score
ranging from 0 to 8 (Gélinas et al., 2009).
10. Sedation: drug-induced state of consciousness depression during which patients may respond
purposefully to verbal commands, either alone or accompanied by light or repeated tactile
stimulation (Naguelhout & Plaus, 2014). No interventions are required to maintain a patent
airway, and spontaneous ventilation is adequate. Cardiovascular function is usually maintained.
Summary
Early assessment of pain in nonverbal patients provides the framework for a process that can
be used to manage pain. Studies suggest that observational instruments help to determine the
presence of pain early and can be used to evaluate the effectiveness of interventions and decrease
pain symptoms before the threshold of pain is reached. A behavioral score is not a pain intensity
score, but the benefits for early pain intervention with the patients are greater.
Symptom management theory clearly establishes that the assessment of acute pain is a
component of the symptom management process. The early assessment of acute pain directly
improves and guides nursing interventions, as well as the development of symptom management
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strategies. The most important goal is the early elimination of acute pain symptoms to minimize
distress, which affects optimal recovery from surgery.
Early assessment and management will improve the relief of acute pain achieving the needed
level of comfort for the patient to function adequately. In postoperative patients, a decrease in
complications, morbidity, mortality and achievement of functional goals means early discharge
and less costs for the patient and the institution.
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CHAPTER 2
REVIEW OF THE LITERATURE
Introduction
Acute pain is an expected symptom that represents significant concern for surgical
patients during the postoperative period. The ultimate goal when dealing with acute pain is the
quality of pain management. For many years, studies devoted to the assessment of pain during
the postoperative period have focused on pain intensity instruments. In 1997, Puntillo and others
addressed the need for reliable and valid instruments for patients unable to verbally report the
level of pain (Puntillo, Miaskowski, Kehrle, et al. 1997). Despite these efforts, guidelines,
standards of practice, and research over the past decades, the undertreatment of pain continues to
be present.
Many factors contribute to poor pain management, but the lack of assessment and
inadequate management are the primary modifiable factors (McCaffery, 2002). The Post
Anesthesia Care Unit (PACU) is the most common hospital setting where patients experience
acute pain. An important part of the recovery period after surgery is the appropriate control of
pain during rest and with activity (Barr et al., 2013). Appropriate postoperative pain alleviation
helps patients return to satisfactory functional status.
This review of the literature addresses the topics of pain, acute pain, postoperative acute
pain, pain nociception, neuroendocrine response, and pain assessment and management during
the early postoperative period. The emphasis of this review is acute pain symptom assessment in
adult non-verbal patients during the early postoperative period. Postoperative pain can be
effectively managed, but in many cases it is not well assessed. Early assessment is an essential
instrument for the adequate management of pain and could increase the adequate administration
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of analgesics during the early postoperative period. It is important to highlight that inadequate
postoperative pain assessment and management, directly affects the patient’s recovery and
satisfaction.
Search for Review of the Literature
A search was initiated in October 2012 and throughout the process. Databases used for
this review of the literature included Cumulative Index of Nursing and Allied Health Literature
(CINAHL), Pub Med, Cochrane Library, Academic Search Premier, Google Scholar, Medline,
and ProQuest. The databases were searched using the key words, alone and in combination,
including: pain, acute pain, pain physiology, surgery stress, postoperative pain, acute pain
assessment, acute pain management, behavioral pain scales, pain assessment instruments, nonverbal pain scales, symptom management, non verbal pain scales, nursing and pain assessment,
critical care pain observation tool (CPOT), nonverbal pain scale revised (NVPS-R), and early
postoperative period. Inclusion criteria included these terms: qualitative or quantitative studies,
systematic reviews, and literature reviews pertaining to pain assessment, reference of care from a
nursing and health care provider that included nurses, and written in the English language. The
goal of this review was to integrate findings on pain assessment and non-verbal patients. All
abstracts were; excluded were articles not written in English, and studies in pediatric population,
because pain behaviors in this population differ from those of adults. A review of reference lists
of all selected articles was also conducted.
Pain
In 1968, McCaffery defined pain as "whatever the person experiencing says it is, existing
whenever he says it does" (Pasero & McCaffery, 2011; Sipos & Karapas, 2010). This definition
allowed healthcare providers to intervene and treat patients on the basis of the self-report of the
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pain experience. Over time, the definitions of pain have been further refined to include the fact
that a person's inability to verbally communicate does not eliminate the possibility that pain is
present or that healthcare providers have a responsibility for treating it (Pasero & McCaffery,
2011). The definition of pain endorsed by the International Association for the Study of Pain and
the American Pain Society both define pain as “an unpleasant sensory and emotional experience
associated with actual or potential tissue damage, or described in terms of such damage” (IASP,
1979). This definition describes pain as a phenomenon with multiple components that makes an
impact on a person’s psychosocial and physical functioning (McCaffery & Pasero, 1999). Pain is
often classified as acute or chronic, based on duration and origin. Acute pain includes
postoperative pain that subsides as healing takes place. Chronic pain is persistent and is
subdivided into cancer-related pain and nonmalignant pain, such as arthritis, low-back pain, and
peripheral neuropathy (McCaffery & Pasero, 1999). Pain is classified by its pathophysiology into
two major types: nociceptive and neuropathic. Nociceptive pain involves the normal neural
processing of pain that occurs when free nerve endings are activated by tissue damage or
inflammation (Pasero & McCaffery, 2011). Neuropathic pain is a persistent, chronic pain that
arises as consequence of central and peripheral nerve damage (Pace, Mazzariello, Passavanti,
Sansone, Barbarisi, & Aurilio, 2006).
Acute pain
Acute pain results from activation of the pain receptors (nociceptors) at the site of tissue
damage. This type of pain is nociceptive and generally accompanies surgery, traumatic injury,
tissue damage, and inflammatory processes. Acute pain is typically self-limiting and resolves in
a short period of time (less than four weeks), alerts the body that it has been injured, and is the
result of tissue injury that corresponds to a healing process. It is a sharp, localized pain of rapid
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onset (IASP, 1979; Barr, 2013), and implies tissue damage that is usually from identifiable
causes such as burns, trauma, surgery, disease and several medical conditions such as myocardial
infarction (Courtenay & Carey, 2008). For the purpose of this review, acute pain will be defined
as pain that is present in a surgical patient after a procedure (ASA, 2012).
Patients can perceive acute pain during any activity or procedure in acute care settings,
intensive care units (ICU), or long-term care settings (Plante & Van Itallie, 2010). Acute pain
includes other physical and psychological symptoms that create distress and stimulate the
sympathetic nervous system creating a disruption to homeostasis (Barr, 2013). The transmission
of acute pain is very complex with many different types of substances produced and utilized to
help or block pain transmission (D’Arcy, 2011).
Physiology of Pain Nociception
The transmission of the sensation of pain requires the activation of different mechanisms
within the peripheral nervous system and central nervous system (Argoff, 2001). To transmit and
facilitate pain sensation, a series of complicated inhibitory and excitatory process occur,
including the production and utilization of neurotransmitters, cytokines, glutamate, and
substance P (American Society for Pain Management Nursing (ASPMN), 2010; Sorkin, 2005).
Between tissue damage and pain perception, lie a complex of electromechanical events
called nociception. Nociception involves physiologic processes of transduction, transmission,
modulation, and perception of pain. Transduction implies the translation of noxious stimuli into
electric activity at the sensory endings of the nerves. Transmission is the impulse propagation
through the sensory nervous system. Modulation is the process where nociceptive transmission is
modified through neural influences and perception is the final process where the other three
processes interact with the person’s psychology to create the final individual experience of pain.
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In visceral tissue the transduction process of nociception is supplied by afferent
sympathetic nerve fibers. The nociceptive signal is transmitted from the surgical site to the
central nervous system. After incision and surgical injury, nociceptors become hypersensitive to
noxious stimuli, a process called sensitization. The transmission takes place at the spinal cord,
ascending via tracts to the thalamus, hypothalamus and brain stem to the somatosensory cortex
for the sensory, discriminative, affective, and motivational aspects of the pain perception. Finally
the modulation occurs at the central nervous system in which descending antinociceptive
pathways can be activated by pain.
Tissue damage from the surgical incision releases chemical mediators, such as
prostaglandins, bradykinin, serotonin, substance P, and histamine. These substances then activate
nociceptors, resulting in transduction, or the generation of an action potential (an electrical
impulse). In the second process, the transmission, action potential moves from the site of injury
along afferent nerve fibers to nociceptors at the spinal cord. Release of substance P and other
neurotransmitters carry the action potential across the cleft to the dorsal horn of the spinal cord,
from where it ascends the spinothalamic tract to the thalamus and the midbrain. Finally, from the
thalamus, fibers send the nociceptive message to the somatosensory cortex, parietal lobe, frontal
lobe, and the limbic system, where the third nociceptive and perception process occurs (Sipos &
Karapas, 2010). Perception, the conscious experience of pain, involves both the sensory and
affective components of pain.
Neuroendocrine Stress Response to Surgery and Acute Postoperative Pain
Physiologic responses related to surgery and pain includes marked catabolism, increased
cardiac work and arrhythmogenesis, hypercoagulability, and immunosuppression. Local
mediators released from injured tissue stimulate global inflammatory responses contributing to

18

the stress response. These include interleukins, prostaglandins, bradykinin, and substance P. This
is the characteristic hypothalamic activation of the initial endocrine response to surgery.
Vasopressin also is elevated in plasma during stress. Prolonged elevation of vasopressin levels is
seen after major surgery (Ferrante & VadeBoncouver, 1993).
The surgical stress response is an endocrine, metabolic, and inflammatory response to
surgical injury and is composed of a variety of physiologic changes (Kehlet, 1982). In 1993,
Kehlet defined postoperative pain as a neural stimulus and release mechanism for the surgical
stress response. The correlation between the site and extent of surgery and the magnitude of the
resultant hormonal stress response presumably reflects the graded actions of neural pathways.
Thoracic procedures or those involving deep tissue in the abdomen evoke quantitatively greater
responses (Ferrante & VadeBoncouver, 1993).
Peak concentrations of thromboxane B2 and serotonin occur 1-2 hours after skin
incisions. Mediators released from injured tissue directly contribute to the stress response by
traveling through the circulation to influence distant target organs. Mediators indirectly
contribute to the stress response by augmenting afferent nociceptive transmission (Ferrante &
VadeBoncouver, 1993), and the early phase of the stress response within the first 24 hours
following surgery. Pain induced reflexes can increase cardiac oxygen demand, vulnerability to
fibrillation, impair respiratory function, and increase the risk of postoperative thromboembolism.
Other adverse effects of uncontrolled postoperative pain include slow recovery from
surgery, increased morbidity in the postoperative period, delayed resumption of normal
pulmonary function, restriction on mobility contributing to thromboembolic complications,
nausea and vomiting, increased systemic vascular resistance, cardiac work and myocardial
oxygen consumption due to excessive catecholamine excretion (Rawal, 1982).
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In general, tissue injury due to surgery causes acute pain and the release of inflammatory
mediators such as substance P, cytokines, eicosanoids, and bradykinin, that contributes to the
initiation and maintenance of the stress response.
Acute Postoperative Pain
Data suggest that, in the United States, 80 percent of patients experience pain
postoperatively (Apfelbaum, Che, Mehta et al., 2003) and have a 50% to 80% chance of
experiencing unrelieved pain (Curtiss, 2001, Warfield C, & Kahn C., 1995). These statistical
data provide relevant information that clearly establishes the need to continue to develop new
strategies for the assessment of pain. Such statistics demonstrate a large number of patients could
potentially be suffering from inadequate postoperative pain assessment and management in the
early postoperative period.
Acute pain management during general anesthesia begins in the operating room during
induction and maintenance of anesthesia and surgery. General anesthesia involves combining
medications from several different drug classes and encompasses five components:
unconsciousness, amnesia, analgesia, immobility, and attenuation of autonomic nervous system
responses to noxious stimuli (Morgan, Mikhail, & Murray, 2006). During general anesthesia,
opioids are used to provide primary or supplemental analgesia in combination with other
anesthetic agents. When inhalation agents are used as the primary anesthetics for general
anesthesia, opioids are commonly employed to provide supplemental analgesia (Heltemes,
2007). All of these medications affect the postoperative recovery from sedation and result in
patients having to stay under moderate sedation during the early post operatory period.
Post-surgical patients develop acute pain that triggers a number of physiological
responses in the human body. The physiological responses that activate the sympathetic nervous
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system increase those responses, and the patients develop other symptoms associated with acute
pain that make it more difficult to regain cardiac, pulmonary, gastrointestinal, musculoskeletal
and cognitive function. Associated symptoms include increase in endogenous hormones such as
epinephrine, cortisol, and renin, and increases in heart rate, hypertension, fatigue, muscle
spasms, sleeplessness, anxiety and depression (Mc Caffery & Pasero, 1999).
Unrelieved pain produces a state of heightened sympathetic tone and a resetting of the
baroreceptor reflex. Heart rate and blood pressure are both elevated. Cardiac work and
myocardial oxygen consumption increase, predisposing to myocardial ischemia. Pain also
produces a reflex reduction in parasympathetic outflow. The distorted balance of sympathetic
and parasympathetic tone that accompanies pain alters the normal relationship between heart rate
and arterial blood pressure (baroreceptor reflex). This resetting of the baroreceptor reflex yields
an abnormally high heart rate for a given blood pressure.
The goal of the acute pain management after surgery is to prevent complications and
improve postoperative outcomes. Postoperative acute pain in the post anesthesia care unit
(PACU) is an expected symptom after surgery and is estimated to be present continuously during
the first 24–48 hours after surgery (Gordon, Pellino, Miaskowski, et al. 2002). The patient first
becomes aware of surgical pain in the PACU. Pain levels are measured frequently and most
PACU policies require that patients attain a specific level of comfort before the patient is
transferred to another unit.
Acute Pain Management
It is clear that acute pain requires a number of complex and physiologically based
interventions to inhibit the transmission of pain impulses and achieve pain alleviation, however
the basic standard for management includes accurate assessment and administration of opioid
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and non-opioid medications as the most important management intervention. It is important that
acute pain be effectively treated because if it persists, a number of physiological responses can
limit patient recovery and cause physiologic stress.
With careful planning, multimodal analgesic techniques, and accurate assessment of the
characteristics of pain, the appropriate selection of drugs at the precise timing minimize the
patient’s side effects (Ganhdi, Baratta, Heitz, Schwenk, Vaghari & Viscusi, 2012). Major areas
of concern regarding postoperative pain management are safety, cost, and concern over side
effects (Ferrante & VadeBoncouver, 1993). For pain inhibition, encephalin, serotonin,
norepinephrine, and gamma-amino butyric acid must be activated (American Society for Pain
Management Nursing (ASPMN), 2010; Sorkin, 2005). Fear of drug addiction and the side effects
of pain medications (especially respiratory depression) has led nursing staff to withhold
medication, which is an absolute error. The aim of postoperative analgesia is to dissociate tissue
injury and mediator release from their usual hormonal sequelae (Ferrante & VadeBoncouver,
1993). Adverse outcomes that may result from the undertreatment of acute pain include
thromboembolic and pulmonary complications, additional time spent in an intensive care unit,
PACU or hospital, needless suffering, and impairment of health related quality of life.
Acute Pain Measurement
The patient's self-report is the most reliable indicator of pain and the sole indicator of
pain intensity (Herr, Coyne, Key, et al., 2006; Pasero & Mc Caffery, 2011). If a reliable selfreport of pain cannot be elicited, the next step is to consider whether the patient has a condition
associated with pain or is undergoing procedures that are generally considered painful. In such
cases, the nurse should "assume that pain is present" (Pasero & Mc Caffery, 2011). The
assumption that a patient who is unresponsive or nonverbal is not feeling pain is completely
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erroneous.
The difficulty in measuring acute pain in postoperative patients under moderate sedation
points to the need for accurate and reliable instruments that provide better evaluations and pain
control. Despite the inherent difficulties in assessment, routine quantification of postoperative
pain is of utmost importance for the quality of pain management. Unfortunately, most of the
existing assessment scales are designed for use with patients who can respond verbally to
assessment commands (Odhner, Wegman, Freeland, Steinmetz, & Ingersoll, 2004) including
postoperative patients after general anesthesia.
The patient’s individual pain trajectories, assessment of pain modulating processes, and
the patient’s psychological status (Davis, Billings, & Ryland, 1994) improve acute pain
management. When medications are administered, nurses need to establish a baseline of pain.
Appropriate pain assessment is the most reliable instrument and foundation for effective pain
management. During the postoperative period, pain assessment must be brief and simple to
complete (Carr, Jacox, Chapman, et al. 1992).
Each healthcare setting needs to establish a clear and effective procedure for evaluating
acute pain symptom presence and the treatment response in sedated or awake patients in the
PACU. The ASA recommends that healthcare providers use standardized, validated instruments
to facilitate the regular evaluation and documentation of pain intensity, the effects of treatment,
and treatment side effects. The ASA also strongly suggests/recommends that patients who are
critically ill, cognitively impaired, or have communication difficulties due to sedation may
require additional interventions to ensure optimal acute pain management (ASA, 2012).
Generally in the PACU, when patients that do not have a verbal response arrive, the nurses
assume that pain isn’t present. Current literature isn’t sufficient to evaluate the application of
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pain assessment methods or pain management techniques specific to this population. This area of
assessment needs more research and development.
The ability to reliably assess patient’s pain is the foundation for effective pain treatment.
As the International Association for the Study of Pain (2010) states, “the inability to
communicate verbally does not negate the possibility that an individual is experiencing pain and
is in need of appropriate pain-relieving treatment”. Therefore, clinicians must be able to reliably
detect pain, using assessment methods adapted to a patient’s diminished communication
capabilities. In such situations, clinicians should consider patients’ behavioral reactions as
surrogate measures of pain, as long as their motor function is intact (Anand & Craig , 1996).
Detection, quantification, and management of pain in critically ill adults are major priorities and
have been the subject of research for over 20 years (Puntillo, 1990). Despite this fact, the
incidence of significant pain is still 50% or higher in both medical and surgical ICU patients
(Chanques, Sebbane, Barbotte, et al., 2007; Payen, Chanques, Mantz, et al. (2007).
Unfortunately during the postoperative period in first hours post anesthesia during the
postoperative period, many factors such as the administration of sedatives, hypnotics, and
adjuvants may alter the level of consciousness which impacts communication of healthcare
providers with patients. These obstacles make pain assessment more complex. The use of
appropriate communication methods may reduce patients distress associated with the presence of
pain. When the patient is unable to communicate in any way, observable behavioral indicators
become unique indices for pain assessment.
Acute Pain Assessment in Non-verbal Patients
Appropriate pain assessment is the foundation of effective pain treatment. Because pain
is recognized as a subjective experience, the patient’s self report is considered the most valid
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measure for pain and should be obtained as often as possible (Loeser & Treede, 2008). During
the perianestesia period, especially during the first hours of the postoperative period, the
administration of anesthetics and sedative agents interfere with the level of consciousness. This
alteration in the patient’s ability to communicate makes pain assessment difficult.
Recognizing that certain behaviors may indicate pain, researchers have developed
behavioral pain assessment instruments for use in patients who cannot self-report. Many of these
instruments yield a behavioral score that can help determine the presence of pain, and when
changes are noted, can be used to evaluate the effectiveness of interventions; however, a
behavioral score is not a pain intensity score. If the patient cannot report the intensity of his or
her pain, then the intensity is unknown (APS, 2008; Herr, 2011; Barr et al., 2013).
For sedated and postoperative non verbal patients the ASPMN published a position
statement that recommends a comprehensive, hierarchical approach to the assessment of pain
(Herr, Coyne, Key et al., 2006), which provides the framework for a decision-making process
that can be used to manage pain (Pasero & McCaffery, 2011;Herr, Coyne, & Key, 2006). A
complete pain assessment is vital and difficult for patients who are nonverbal, sedated,
cognitively impaired, or unable to provide a self-report of pain. Unfortunately, most of the
existing assessment scales are designed for use with patients who can respond verbally to
assessment commands. Consequently, medication management in nonverbal patients is often
guided by less precise and wholly untested methods of medication impact (Odhner, Wegman,
Freeland, Steinmetz, & Ingersoll, 2004).
Behavioral scales are available and highly recommended by the Critical Care Medicine
Association, American Society of Perianesthesia Nurses, American Society of Anesthesiologists,
and American Pain Society among others, for the assessment of acute pain in nonverbal patients.
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Observational behavioral ratings scales were not equivalent to self-reported intensity ratings. The
most validated behavioral rating scales for non-verbal adult patients include five pain scales:
Behavioral Pain Scale (BPS); Critical-Care Pain Observation Instrument (CPOT); Non-Verbal
Pain Scale (NVPS-R); Pain Behavioral Assessment Instrument (PBAT); and the Pain
Assessment, Intervention, and Notation (PAIN) Algorithm (Stites, 2014; Barr et al. 2013).
Although the literature presents the BPS and the CPOT as the most valid and reliable
behavioral pain scales for monitoring pain in medical, postoperative and adult ICU trauma
(except for brain injury) patients who are unable to self-report (Barr et al., 2013), the evidence
does not suggest their applicability for patients in the early post operatory period. For purposes
of this study, the BPS instrument will not be considered since it was designed for intubated
patients; our interest resides on patients under moderate sedation who are not intubated.
Behavioral Pain Scales
Pain algorithm (PAIN)
The PAIN algorithm was developed in 2001 and is divided into the components of pain
assessment, the patient’s ability to tolerate opioids, and guidelines for analgesic treatment
decisions and documentation (Puntillo, Stannard, Miakowski, Kehrle, & Gleeson, 2002). The
pain assessment section of the instrument contains behavioral (movement, facial cues, posturing)
and physiological (increased heart rate, respiratory rate, and blood pressure and perspiration or
pallor) dimensions, which are similar to the NVPS-R instrument, with differences in the second
and third components of the instrument.
Although this instrument was tested in postoperative patients, there are some disadvantages
that affect the decision to consider this instrument as a comparative one for acute pain
assessment in this study. The first is the insufficiency of data to establish its reliability and

26

validity. Another reason is the inclusion of analgesic treatment decisions and documentation,
which is not a criteria included in the CPOT as a comparable instrument. Finally and most
importantly, the extensiveness of the instrument, for it does not facilitate an early assessment,
which is the focus of this study.
Non-verbal pain assessment instrument (NPAT)
The NPAT nonverbal pain scale consists of five observational subscales of behavioral
indicators for pain: emotion, movement, verbal cues, facial cues, and positioning/guarding
(Klein, Dumpe, Katz, & Bena, 2010). Two separate scoring systems are provided on the
instrument for use in both verbal and nonverbal patients, each one with a score from 0 to 10
points.
Validity results were moderately strong when the NPAT was compared with the standard
self-report in the third phase. The instrument was designed for nonverbal critical care patients,
however has not been validated in this population. The scale testing was conducted with verbal
medical-surgical patients, so it was not be considered for use in this study.
Non-verbal pain scale revised (NVPS-R)
The original NVPS was based initially based on the Faces, Legs, Activity, Cry,
Consolability (FLACC) pediatric scale (Odhner, Wegman, Freeland, Steinmetz, & Ingersoll,
2004). Like the PAIN algorithm and the NPAT, the original NVPS contained behavioral
categories (facial expression, activity, and guarding) and physiological categories (heart rate,
blood pressure, and respiratory rate) that are graded in severity, and a final category physiologic
II included autonomic indicators such as dilated pupils, diaphoresis, flushing, or pallor. The
NVPS was revised on 2003 and autonomic indicators was substituted with respiratory category
(respiratory rate, pulse oxygen saturation), and was renamed NVPS-R. Each domain is ranked
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from 0 to 2, with a total score between 0-2 (no pain) and 3-10 (significant pain presence).
The original NVPS rated facial expression, activity, guarding, change in vital signs
(physiologic I), and other physiological signs (physiologic II). NVPS-R was most valid and
reliable assessment instrument than the original NVPS for sedated ICU patients receiving
mechanical ventilation. In 2009, Kabes, Graves & Norris conducted a further validation of the
revised NVPS-R in comparison with the original version. The revised version shows the validity
and reliability of the observational instrument for assessing pain in an ICU population of patients
who are sedated and receiving mechanical ventilation but are not paralyzed. Furthermore, The
revised NVPS-R includes a new “respiratory” category that replaces the physiological II
dimension of the original scale (Wegman, 2005). The dimension includes an assessment of the
amount of deviation from the baseline respiratory rate, as well as oxygen saturation as measured
by pulse oximetry and level of compliance with the ventilator. Using a non-experimental design,
nurses in a trauma-surgical ICU assessed patients before, during, and at rest after a painful
nursing procedure.
In 2010, Marmo and Fowler used a repeated-measures study design to examine the
validity of the NVPS-R in a sample of 25 critically ill patients after open-heart surgery. The
NVPS-R, CPOT, and FLACC were administered for a total of 300 paired, independent
observations before, during, and after a painful procedure. This study included postoperative
patients in critical care unit.
In 2011, Wibbenmeyer et al., in a sample of 38 burn patients, conducted a similar study.
A total of 225 paired assessments were completed by nursing staff who were “briefly educated”
on use of the CPOT and the NVPS-R. This study was similar to the proposed study. Due to the
characteristics of the NVPS-R this instrument could be used for the assessment of pain in

28

patients in the PACU, however validation is needed in this specific setting.
Critical care pain observation tool (CPOT)
Behavioral indicators are strongly recommended for pain assessment in nonverbal patients and
several instruments have been developed and tested in critically ill adults including the Critical
Care Pain Observation Tool (CPOT) (Gélinas et al., 2006). The CPOT was tested in verbal and
non-verbal patients (Gélinas & Jonhston, 2007; Gélinas & Arbour, 2009; Gélinas et al., 2006).
Content validity was supported by critical care unit expert clinicians, including nurses and
physicians (IASPN, 2007).
The CPOT was designed for use in both intubated and non-intubated critical care
patients. Four indicators are scored from 0 to 2: facial expressions, movements, muscle tension,
and ventilator compliance for intubated patients or vocalization for non-intubated patients; total
scores range from 0-2 (no pain presence), 3 to 8 (significant pain presence). Content validity
index of all indicators was 0.88 to 1.0, according to an analysis of the results of a questionnaire
provided to physicians and critical care nurses. The CPOT was originally developed in French
and was tested in a convenience sample of 105 cardiac surgery patients. Those patients were
admitted to an ICU.
In 2006, Gélinas and Johnson used a repeated-measures design and trained data collectors
to obtain the CPOT score of 105 patients at 3 times: at rest, immediately after repositioning
(nociceptive procedure), and at recovery (20 minutes after repositioning). After completion of
the assessment by 2 observers, the patient was asked to indicate the presence or absence of pain
by nodding the head yes or no. Inter rater reliability was moderate to high (weighted
coefficient = 0.52-0.88) when tested between the same 2 data collectors.
Discriminate validity was established by detection of elevations in heart rate and blood

29

pressure that occurred in accordance with elevated CPOT scores. Yet, physical motion is known
to increase heart rate and blood pressure to compensate for increased oxygen demand, making
this method of establishing validity problematic. However, when patients’ self-reported pain
values were compared with the observer-derived CPOT scores, the positive predictive value of
the CPOT was high (85.7%).
The majority of the nurses also reported that the CPOT was quick to use (78%) and that
they would recommend use of the CPOT routinely in practice (72.7%)(Gélinas, 2010). Also, in
2010, Marmo and Fowler tested the CPOT in patients after heart surgery and found that the
instrument had high reliability (α = 0.89). These researchers were also the first to report the
internal consistency of the CPOT (56%-100% agreement). The CPOT was also included in the
previously discussed study by Wibbenmeyer et al., 2011 who reported a high internal
consistency (Cronbach α, 0.71) and good discriminate validity (mean scale scores = 0.27 at rest
to 0.56 after noxious stimulation).
Vázquez et al., 2011 conducted a prospective, repeated-measures study in a 12-bed
general ICU in Spain. A total of 330-paired observations were completed in a study sample of 96
critically ill patients. Observations were conducted before, during, and after a repositioning
procedure. Inter-rater reliability of the CPOT was excellent (κ = 0.79), and discriminate validity
was good; mean scores were 0.27 (SD, 0.64) at rest and 1.93 (SD, 1.41) during the procedure.
When pain assessment practices were analyzed by using descriptive statistics, reports of
pain assessments were 3 to 4 times more frequent after implementation than they were before
implementation. Interestingly, implementation of the CPOT was associated with decreased
frequency of administration of sedatives and analgesics. Gélinas et al. (2011) provided 2 possible
explanations: increased ability of nursing staff to discern pain from other symptoms (such as
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anxiety) or decreased number of trauma patients in the group after implementation due to a
change in the center’s trauma designation.
The PAIN algorithm and NPAT have each been used in only a single study, and the
findings in both studies were of limited value. The original testing of the NVPS-R is of limited
value because of the study’s non-experimental design and the use of the FLACC pediatric scale
as the gold standard for comparison.
The NVPS-R is the only instrument that includes dimensions of physiological data; these
indicators have been some of the least sensitive markers for the presence of pain (Pasero & Mc
Caffery, 2005).
An overwhelming majority of the studies provide support for the reliability and validity
of both the BPS and the CPOT in detecting pain in nonverbal critically ill adults. Of the available
observational pain scales, the CPOT has shown superior reliability and validity when used in
nonverbal critically ill adults. Thus far, the validation of observational pain scales has been for
use in cognitively impaired patients and critically ill patients in the intensive care units, who are
sedated (Kabes, Graves, & Norris, 2009) but not for sedated patients in the PACU.
A group of Canadian nurse investigators described observable physiological and
behavioral indicators of pain (Gélinas, Fortier, Viens, Fillion, & Puntillo, 2004). In 2005 Pasero
and McCaffery pointed out that heavily sedated patients might have severe pain but be unable to
move. The BPS focuses on behavioral observations only (facial expression, cry, and
movements), whereas the NVPS-R includes behavioral and physiological indicators. However,
physiological indicators should not be used as the sole indicators of pain level.
The NVPS-R is similar to the CPOT pain scale (ASPMN, 2010). The CPOT appears to
be a better instrument to detect pain in intubated post open-heart surgery adults compared with
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the NVPS-R, as evidenced by better agreement between nurse raters. Further research is
necessary to assess the reliability of the CPOT in other patient populations, including nonintubated, non-verbal patients. Nurses require an easy pain assessment instrument to use with
clear descriptors for each item of the instrument and takes limited time to complete the
assessment. The implementation of a new practice in any setting requires careful planning, staff
involvement, motivation, training, and resources.
Richmond Agitation Sedation Scale (RASS)
The RASS is the most valid and a reliable instrument for assessing depth of sedation (Barr et
al., 2013) and to quantify agitation severity in patients receiving sedative medications (MartínezCastillo et al., 2013) in various settings. The RASS assesses the level of consciousness and
agitated behavior of patients. The scale has a single-item numerical structure that involves the
description of four levels of agitation (from 1- restless, to 4 - combative) and five levels of
sedation (from -1- somnolence, to -5 - unarousable)
The original psychometric analysis of the RASS included in the 2013 Pain, Agitation, and
Delirium guidelines included eight studies with over 1,600 ICU patients (Sessler et al., (2002).
Six additional RASS studies have been published since 2010, for a total of over 3,400 ICU
patients studied using RASS (Wessley et al., 2003). The validity and reliability of the scale has
been established in intensive care unit patients (Sessler et al., 2002).
Sedative medications are commonly administered to patients before and during surgery. To
measure sedation levels, the RASS scale is applicable in postoperative patients after surgery and
general anesthesia. Postoperative patients can suffer reduced awareness resulting from the use of
medications used to induce and maintain a state of general anesthesia. In these clinical situations,
the RASS is a useful instrument for evaluating patients’ reduced awareness due to sedation and
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to establish if a verbal or non-verbal instrument is adequate to assess acute pain.
The literature states that objective measures of brain function, such as auditory evoked
potentials or bi-spectral index, are not to be used to assess depth of sedation as a primary source
in non-comatose, adult patients (Barr et al., 2013). The RASS presented the highest
psychometric scores, high degree of inter-rater reliability, convergent or discriminant validation
when compared to other similar scales and had a robust number of study participants (Brandl,
Langley, Riker, et al., 2001; Ryder-Lewis & Nelson 2008). The scale discriminates different
sedation levels in many clinical situations, including with postoperative patients (Ely, Truman,
Shintani, et al., 2003).
Summary
Literature suggests that existing validated instruments for use in the assessment of acute
pain in the early post operatory period and the pain management for patients under moderate
sedation are lacking and research is warranted. Pain needs to be assessed beginning at admission
to hospital and at regular intervals. Based on the principle of justice, all patients have the right to
receive comparable care, including those who cannot report acute pain.
Unfortunately, acute pain remains prevalent. Pain measurement is complex, however, the
basis for quality pain management is assessment using of reliable and valid instruments (Ferrante
& VadeBoncouver, 1993). There is also a requirement that pain be reassessed after patients are
medicated for pain to determine if the medication has relieved the pain (Barr et al., 2013). There
is ample evidence that the appropriate use of analgesics at the right intervals can provide good
pain relief for patients (Dolin, Cashman & Bland, 2002). The issue is the selection of the
appropriate instrument to measure pain in the early postoperative period.
Health care organizations have the responsibility to develop processes to help support
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improvements in pain management, including methods to ensure the recognition of patients’
rights for suitable pain assessment and management, appropriate assessment of the severity of
pain; regular pain assessment, recording, and follow-up; and establishment of policies and
procedures that supports the appropriate prescription of pain medications (JCAHO, 2000). Pain
scales need to be appropriately and consistently used for individual patients. Nurses need to be
educated on the use of pain scales with special attention to the interpretation of each behavior or
item on the instrument for accurate assessment and subsequent interventions.
Adequate pain management requires interdisciplinary evaluation and management. Welldocumented pain assessments and interventions are essential to maintain effective
communication between healthcare providers and monitor patients responses to acute pain
management. The quality of acute pain management needs to emphasize the importance of the
continual assessment to effectively improve pain treatment.
Currently, the literature is insufficient to evaluate the application of pain assessment
methods or pain management techniques in nonverbal patients in the early post-operative period.
This group of patients includes the critically ill, cognitively impaired, or patients with
communication difficulties, such as patients after surgery. These patients require additional
assessment and management considerations. Regular pain assessments and documentation of
pain scores are an important component of an acute pain service program as it increases the
likelihood that patients’ pain remains below an acceptable threshold (Sinatra, 2010) to prevent
and/or decrease postsurgical complications.
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CHAPTER 3
METHODS
Background
Unrelieved postsurgical pain can lead to multiple complications that can delay recovery and
lead to increased morbidity and mortality. The efforts of this study are directed at developing the
scientific underpinnings to provide anticipatory pain management in the PACU for patients to
promote faster recovery. One critical gap in developing this knowledge is the ability of nurses to
evaluate pain in sedated non-verbal patients to provide better pain management before critical
pain thresholds are exceeded.
Research Question
Two non-verbal instruments to evaluate pain in adults have been identified in the literature,
but neither of these instruments has been previously tested in sedated, non-verbal patients in the
post anesthesia care unit during the immediate postoperative period. Thus, the proposed research
aimed to develop baseline measures of pain with these instruments that might subsequently be
used to provide anticipatory pain management. Thus, this study addressed the following
question: What is the relationship between the Critical-Care Pain Observation Instrument
(CPOT) and the Non-Verbal Pain Scale (NVPS-R) when used during the assessment of acute
pain for patients under sedation in the PACU?

Specific Aims


Aim 1 -To describe the relationship between pain scores obtained using the NVPS-R and
CPOT assessment instruments, when administered upon arrival to the PACU, among
patients undergoing major abdomino-pelvic, gynecologic, or gastrointestinal surgery.
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Aim 2 - To describe the relationship between pain scores obtained using the NVPS-R and
CPOT assessment instruments, when administered 120 minutes after arrival to the
PACU, among patients undergoing major abdomino-pelvic, gynecologic, or
gastrointestinal surgery.



Rationale Specific Aim 1 and Aim 2 - This study used the CPOT and the NVPS-R, to
determine whether one instrument is best when assessing this population because it will
describe the extent to which of the two scores is more predictive of pain. If one is found
to be more predictive than the other, under those circumstances, the instrument that is
simpler or faster for use by clinicians will be best.



Aim 3 - To describe the change in pain scores over time obtained using the NVPS-R
assessment instrument, when administered to patients undergoing major abdominopelvic, gynecologic, or gastrointestinal surgery at the following time points (minutes)
following arrival to the PACU: 0, 15, 30, 45, 60, 90 and 120.



Aim 4 - To describe the change in pain scores over time obtained using the CPOT
assessment instrument, when administered to patients undergoing major abdominopelvic, gynecologic, or gastrointestinal surgery at the following time points (minutes)
following arrival to the PACU: 0, 15, 30, 45, 60, 90 and 120.



Rationale Aim 3 and Aim 4 – The rationale for this research is to contribute to the
literature additional knowledge of the course of pain over time among non-verbal sedated
patients. The usefulness of this information is that it might guide the development of new
and better protocols for providing anticipatory pain relief.



Aim 5 - To describe the relationship between the change over time in pain scores
obtained using the CPOT assessment instrument and the NVPS-R assessment instrument,
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when administered to patients undergoing major abdomino-pelvic, gynecologic, or
gastrointestinal surgery at the following time points (minutes) following arrival to the
PACU: 0, 15, 30, 45, 60, 90 and 120.


Rationale Aim 5-The rationale is to describe if the two assessment instrument scores
over time are predictive of one another. If the predictive significance of one assessment
instrument is sufficiently high, then the two instruments are equivalent. Under those
circumstances, the simpler or faster instrument is best for use.
Study Design
This exploratory study used an observational cohort, correlational, single-group, repeated

measures design to compare and describe the relationships between the Critical-Care Pain
Observation Instrument (CPOT) (APPENDIX C) and the revised Non Verbal Pain Scale (NVPSR) (APPENDIX D), to evaluate acute pain during the early postoperative period.
Behavioral pain assessment was conducted in non-verbal patients after major
abdomino-pelvic, gynecologic or gastrointestinal surgery under general anesthesia. These types
of surgeries were associated with moderate to severe postoperative acute pain due to the involved
dermatomes (neural pathways) that share the same sensorial innervation from sympathetic nerves
from tenth thoracic to the first lumbar spinal cord segments (Ferrante and VadeBoncouer, 1993).
Setting
The Post Anesthesia Care Unit (PACU), at the Medical Services Administration (ASEM)
in the Puerto Rico Medical Center was used for the recruitment of subjects (APPENDIX B).
ASEM’s PACU is an 18-bed acute care facility providing supra tertiary surgical services to adult
patients admitted for management of acute care and trauma surgeries. The PACU is staffed by 35
nurses on average, 6-8 nurses in each eight (8) hour shift turn in 24 hours. On an average day 20-
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35 patients were received daily in the PACU, with an average length of stay of two hours.
Study Population
The study population was comprised of adult male and female patients undergoing
abdomino-pelvic, gynecologic, or gastrointestinal major surgeries who provided consent to be
enrolled in the study. These patients had the expected symptom of acute pain after surgery and
were unable to self-report the level of pain due to the level of sedation. The number of patients
with abdomino-pelvic, gynecologic, or gastrointestinal surgery in the setting ranged from 8-10
per week. The sample included all patients that had previously consented to enroll in the study
during a pre-operative visit. These pre-operative visits usually occurred from 7 days to a few
hours before the surgery. The admitted participant subjects who had major abdomino-pelvic,
gynecologic or gastrointestinal surgeries were enrolled from those individuals who had their
surgery performed by multiple surgeons. Subjects admitted to the PACU after surgery were
unable to self-report the level of pain due to a level of sedation.
In order to be eligible the subject had to be: an adult scheduled for selected surgeries, under
sedation following surgery, with a RASS level of - 4 to -2 (APPENDIX E). Subjects who had
consented were included in the study in the post anesthesia care unit of the Medical Services
Administration (ASEM).
Sample Size and Calculations
Sample size calculations were not performed. Because this is an exploratory study, we
reason that enrolling 40 consenting participants afforded us sufficient precision for confidence
interval estimation of the relationships of interest. Subjects scheduled for abdomino-pelvic,
gynecologic, or gastrointestinal surgeries were identified during their pre-operative visit. Once
identified, subjects were informed and invited to participate in the study. Those who agreed
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were asked to read and sign a consent form and then enrolled in the study.
Inclusion criteria
- Adult 21 years or older.
- Able to provide informed consent.
- Consenting to abdomino-pelvic, gynecologic or gastrointestinal surgery.
- Unable to verbalize or indicate pain by using a traditional verbal scale such as the numeric
rating scale (NRS) upon arrival in the PACU.
-RASS = -4 to -2 (deep, moderate and light sedation)
Exclusion criteria
- Patients able to self -report acute pain, with an initial sedation scale (RASS) = -1, and 0 to 4.
- Patients with history of chronic pain, or moderate to high acute pain previous to surgery.
-Patients with a previous diagnosis of chronic cognitive impairment (Dementia, Alzheimer) or
neurologic impairment (paraplegia, quadriplegia, upper limbs amputations, or stroke), due to the
variability in behaviors presented. This would disrupt patient’s motor functions and the
behaviors evaluated with the non-verbal pain instruments (NVPS-R and CPOT) couldn’t be
observable (Barr et al., 2013).
Recruitment
The potential participants were chosen during the preoperative visit by the investigator. A
preoperative schedule at Surgery and OB GYN clinics was evaluated for inclusion and exclusion
criteria of potential participants. A request for a waiver of authorization for the release of health
information form (Appendix F) from the UPR RCM IRB was used for the purposes of accessing
to personal health information (PHI) prior to consent of participants.
The investigator made the initial contact with the potential participants, informed them
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about the study and asked if they were interested in participating. Upon agreeing to participate in
the study, they were asked to read and sign the informed consent form previously approved by
the Institutional Review Board (APPENDIX F) so that they had the opportunity to review it and
ask any questions regarding participation. They were given a copy of the consent form for their
records, the investigator retained the original, and a copy was placed in the subject’s chart if
required by the medical center. The investigator made note of the date of the surgical procedure
following consent so that the patient could be visited in the PACU following surgery.
Informed Consent
Potential participants were informed that their participation was voluntary and that they
could withdraw at any time before or after the study. Participants were informed that the study
was confidential to comply with ethical and HIPAA guidelines. Each element of the consent
form was reviewed with the subject prior to consent. Two copies of the original informed
consent were printed; one for the PI to keep; one for the participant to keep; and one for the
medical record, if required by the medical center. Approval to use human subjects in this
research was granted by the University of Massachusetts Amherst Human Research Protection
Office (HRPO) and the University of Puerto Rico Institutional Review Board (IRB). Written
consent was required from each participant (APPENDIX F). This was a low risk study because it
involved non-invasive measurements; there was no intervention and no alteration of received
care. Thus, recruitment of the participants took place after an anticipated expedited review from
Institutional Review Board and received approval from the UMASS-HRPO and UPR-IRB.
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Data Collection Procedures
Pre-operative visit surgery day
The data collection procedure began during the preoperative visit, 0 to 7 days prior to the
scheduled surgery (APPENDICES H & J). The PI evaluated the inclusion and exclusion criteria
for each possible participant (APPENDIX K). When it was found that a potential participant met
the inclusion criteria, the PI discussed the study purpose, risks, benefits and confidentiality. If the
potential participant agreed to participate, they were asked to sign a consent form for study
participation (APPENDIX F). We also determined if the participant had any pain at this visit
before their surgery.
Surgery day
A socio demographic data instrument was completed with information during the preoperative visit, in the holding area upon admission for surgery or before arrival to the PACU
(APPENDIX G). Additionally, vital signs including blood pressure, heart rate, respiratory rate,
and oxygen saturation were measured and recorded, before the participant’s arrival to the
operating room.
At PACU arrival
After surgery, upon the participant’s arrival at PACU, the RASS was applied to measure the
level of sedation. If the participant showed a RASS between -2 to -4, indicating a level of
sedation from light to deep, then both non-verbal instruments, the Critical Care Pain Observation
Tool (CPOT) (Gélinas, 2006), and the NVPS-R (Rochester University, 2004) was applied
(APPENDICES C & D). The acute pain assessment with nonverbal instruments was applied at 0,
15, 30, 45, 60, 90, and 120-minute intervals. The order of the assessment instruments application
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was used for randomization between patients. The randomization schedule was identified in
advance.
There was the possibility of some subjects being excluded from the study after having
provided consent due to level of consciousness upon arrival to the PACU. This occurred if a
participant’s RASS score was -5 (unarousable), -1 (drowsy) or the RASS score was 0, +1 to +4,
which indicated a level of wakefulness (Sessler et al., 2008), thus the participant would have
been able to self-report pain.
For documentation purposes, the PI nurse had a demographic data sheet and the
assessment of acute pain instruments. Each bedside pain assessment was performed by the PI
nurse using a data collection form (APPENDIX L) The form included the pain assessment
instruments (CPOT and NVPS-R), for acute pain assessment for each patient. At established
time intervals, the PI nurse rated each patient’s level of pain and recorded their assessments on
the data collection form.
In summary, after all participants were confirmed to have a RASS sedation level
between -2 to -4, they were assessed with both non-verbal pain instruments during the early
postoperative period, immediately after arrival to PACU. After that initial pain assessment,
patients were assessed every 15 minutes until an hour had passed, then every 30 minutes until
another hour had passed, for a total of seven (7) assessments with each instrument during a 2hour period. The number and type of pain medications administered throughout the early
postoperative period were also recorded.
Data Collection instruments
Personal and health information (PHI) that we used or disclosed (released) from medical
records for this research included: Age, gender, and medical record number, discharge time from
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PACU; and health information including American Society of Anesthesiologists (ASA) physical
status, diagnoses, medications used, vital signs, type and length of surgery, anesthesia
administered, lab results, pain assessments, pain presence at discharge, medications administered
and side effects during PACU stay.
To protect the confidentiality of PHI in the records of the study, the following procedures
were used:
PHI was protected through the assignment of a case number. The researchers kept all study
records, including data codes, in the PI’s office. The records were protected according to HIPAA
regulations. A master key that linked names and codes remained separate and in a safe place. The
master key will be destroyed three (3) years after the end of the study.
Electronic files (REDCAP database, spreadsheets), containing all personally identifiable
information was password protected (Harris, Taylor, Thielke, Payne, Gonzalez, Conde, 2009).
Any computers that host files were password protected to prevent access by unauthorized users.
Only the researchers had access to passwords. At the conclusion of this study, researchers will
publish their findings. The PHI is to be presented in a summary and participants will not be
identified in publications or presentations.
A socio-demographic instrument (APPENDIX G) was used to collect data on age, ethnicity,
sex, education, and weight. Other important data to be included was diagnoses and the level of
pain during the pre-operative visit and during the day of the surgery before the procedure. All of
this information is important to analyze results and establish relationships amongst the variables.
As stated earlier, the RASS instrument was first used to establish sedation level (APPENDIX E),
then two behavioral pain assessment instruments were used for this study, CPOT (APPENDIX
C) and NVPS-R (APPENDIX D). Each instrument was applied for the selected nonverbal
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patients, both instruments at a same time. Permission to use CPOT and NVPS-R instruments was
obtained from the developers of the original scales via e-mail (APPENDIX A).
A data collection form was designed to include the socio-demographic data, pain
assessment score, pain medication administered and other important data (APPENDIX L). At the
end the results of significant acute pain presence measured with each instrument was compared
to established relationships. These instruments have been described earlier in this manuscript.
Richmond Agitation and Sedation Scale (RASS)
The RASS is the instrument used to measure the level of sedation at this study. The instrument
ranged from -5 (unarousable) to +4 (combative). If the RASS score range equaled -1 (drowsy) or
higher, the patient sustained awakening or agitation, then they were either not enrolled in the
study or data collection was stopped. If the score was -2 (light sedation), -3 (moderated
sedation) or -4 (deep sedation), then data collection began immediately in the PACU.
Critical Care Pain Observation Tool (CPOT)
The CPOT has four behavioral indicators that include facial expression, body movement,
and compliance with ventilator for intubated patients or vocalization for non-intubated, and
muscle tension. Each indicator is valued is from 0-2 points, for a maximum total score of 8
points. In this study, the vocalization indicator was used because patients were expected to be
breathing spontaneously. The presence of significant acute pain was defined by a total score
equal to 3 or more (Barr et al., 2013). Subjects who were intubated on a ventilator were not
included to increase the reliability and validity of measures.
Non-verbal Pain Scale Revised (NVPS-R)
NVPS-R includes behavioral and physiological categories. It contains five categories
classified as three behavioral dimensions (facial expression, activity, and guarding), two
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physiological dimensions (heart rate and blood pressure), and a respiratory dimension
(respiratory rate and oxygen saturation) that was graded in severity. Each category is ranked
from 0 to 2, with a total score between 0 (no pain) and 10 (maximum pain). The score from 0-2
indicate no pain, 3-10 indicates significant pain (University of Rochester Medical Center, 2004).
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Data Analysis
Description of the study cohort
Prior to analyses to address the specific aims, the study cohort was described using means,
standard deviations and percentiles for continuous variables and frequencies and relative
frequencies for discrete variables. Variables considered included: demographics, medical history,
plus selected surgery indices (type of surgery, duration of surgery, general anesthesia proposed),
pain presence. Separate descriptive statistics were obtained for discrete and continuous variables
of the population.
Data Analysis
Data Analysis (Appendix I) to Address Specific Aim #1 - To describe the relationship
between pain scores obtained using the NVPS-R and CPOT assessment instruments, when
administered upon arrival to the PACU, among patients undergoing either abdomino-pelvic,
gynecologic, or gastrointestinal surgery.
The nature and strength of the relationship between NVPS-R and CPOT scores was explored
using standard description approaches, Pearson correlation, and linear regression. Descriptive
relationships were assessed through scatter plots. Simple linear regression models were then
fitted to obtain estimates of the correlation in NVPS-R and CPOT scores and a prediction
equation. The dependent variable in these analyses was the NVPS-R score. Thus, we considered
the CPOT for the prediction of the NVPS-R.
Data Analysis to Address Specific Aim #2 - To describe the relationship between pain scores
obtained using the NVPS-R and CPOT assessment instruments, when administered 120 minutes
after arrival to the PACU, among patients undergoing major surgery that is either abdomino-
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pelvic, gynecologic, or gastrointestinal.
Analyses to address Specific Aim #2 will be the same as those for Specific Aim #1.
Data Analysis to Address Specific Aim #3 - To describe the change over time in pain score
obtained using the NVPS-R assessment instrument, when administered to patients undergoing
major surgery that is either abdomino-pelvic, gynecologic, or gastrointestinal and at the
following time points (minutes) following arrival to the PACU: 0, 15, 30, 45, 60, 90 and 120.
Change over time in the NVPS-R score was explored using descriptive statistics, mean,
standard deviation (SD), range of values, and graphs. Because it was expected that pain would
decline with time, the focus of these analyses was a description of the pattern of reduction and
not a test of the null hypothesis of zero change. Descriptive statistics included, for each time
point, regression models fitted to obtain estimates of the mean profile, overall and separately for
sub-groups defined by key variables (eg – type of surgery, type of medications administered,
dose per kilograms, time of administration)
Data Analysis to Address Specific Aim #4-To describe the change over time in pain score
obtained using the CPOT assessment instrument, when administered to patients undergoing
major surgery that is either abdomino-pelvic, gynecologic, or gastrointestinal and at the
following time points (minutes) following arrival to the PACU: 0, 15, 30, 45, 60, 90 and 120.
Analyses to address Specific Aim #4 will be the same as those for Specific Aim #3.
Data Analysis to Address Specific Aim #5 -To describe the relationship between the change
over time in pain score obtained using the CPOT assessment instrument and the change over
time in pain score using the NVPS-R assessment instrument, when administered to patients
undergoing major surgery that is either abdomino-pelvic, gynecologic, or gastrointestinal and at
the following time points (minutes) following arrival to the PACU: 0, 15, 30, 45, 60, 90 and 120.
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Data analysis to address Specific Aim #5- We considered an appropriately defined response
to help us determine any change in scores from one time point to another. To evaluate the change
over time using each one of the assessment tools, we calculated the Wilcoxon Signed Rank for
the difference of the following time points in minutes (0 to 15, 15 to 30, 15 to 45, 15 to 60, 15 to
120). The differences in score for CPOT and NVPS-R were calculated as: change score = score
at 120 minutes – score at 0 minutes, 2). For each patient, this will yield a pair of response
features, summarizing the CPOT and NVPS-R profiles, respectively. Differences reached
statistical significance if p ≤ 0.05.
Sociodemographic data
Descriptive statistics were utilized to describe the demographic characteristics of the sample.
Demographic data included age, type of surgery, general anesthesia administered and diagnoses.
This data provided important information to establish inferences, relationships and correlations
between the studied variables (APPENDIX G).

48

CHAPTER 4
RESULTS
Introduction
The purpose of this study was to determine the relationship between the CPOT and the
NVPS-R for acute pain assessment in the early postoperative period in non-verbal sedated
patients. We performed an exploratory study of 40 patients who underwent major abdominopelvic, gynecologic or gastrointestinal surgery and were in a non-verbal state of sedation in the
early postoperative period. Seven repeated assessments of pain were conducted using both CPOT
and NVPS-R instruments, in minutes post arrival to the PACU at 0, 15, 30, 45, 60, 90, and 120
minutes. A total of 246 assessments were measured with each instrument. Statistical methods
used to explore the relationship between CPOT and NVPS-R pain scores included descriptive
statistics and normal theory regression.
To address and account for the possibility that order of pain assessment (CPOT first or
NVPS-R first) might influence the subsequent pain assessment (NVPS-R second or CPOT
second), our study design also incorporated randomization of the order in which the CPOT and
NVPS-R assessments were performed. Study participants were randomized to group 1 (CPOT
first, NVPS-R second) or group 2 (NVPS-R first, CPOT second). Preliminary analyses of the
data at each time point of measurement included a test of the null hypothesis of zero effect of
group on CPOT and zero effect of group on NVPS-R.
REDCap a research electronic data capture is a secure, web-based application designed to
support data capture for research studies (Harris, Taylor, Thielke, Payne, Gonzalez, Conde,
2009), was used to collect and categorize data. STATA version 14.0 was used to analyze data.
Results from the major study findings are described in this chapter.
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Subject Recruitment
This study was conducted in a Post Anesthesia Care Unit (PACU) located in Medical
Services Administration (ASEM) in the Puerto Rico Medical Center. Fifty- nine patients, 22 to
87 years old, who were scheduled for abdomino-pelvic, gynecologic, or gastrointestinal surgery
between October 20, 2015 and December 7, 2015 were consented for the study. Of these, 19
subjects were excluded. One subject was unable to sign the informed consent form, due to
chronic cognitive impairment. The other 18 patients were excluded because their surgeries were
cancelled (n=8), they received regional anesthesia during surgery (n=5), or because they were
verbal (RASS -1, 0) upon arrival to the PACU (n=5). Thus, the final sample consisted of 40
subjects.
Characteristics of Study Participants
The characteristics of the study participants are shown in Table 1 (discrete variables) and
Table 2 (continuous variables). Both demographics and surgical summaries are reported. The
mean age of the study participants was 49.3

17.1 years. The youngest participant was 22 years

of age, and the oldest was 87 years of age. The mean weight was 79.8

29.4 kilograms. Slightly

over half (52.5%) of the participants had completed secondary education. Participants were
classified using the American Society of Anesthesiologist’s (ASA) physical status classification
system (ASA). The ASA scale varies from 1= healthy patient, 2= mild systemic disease, 3=
severe systemic disease, 4=incapacitating disease, 5=dying patient (Naguelhout & Plaus, 2014).
Ten percent of the patients were healthy (ASA 1) whereas that 67.5% had a mild systemic
disease (ASA 2). The majority of participants 72.5% were female. About 85% were white and
100% were of Hispanic origin.
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Table 1. Characteristics of Study Participants for discrete variables, n=40
Characteristics

Total n (%)

Discrete variables
Randomization
Group 1: CPOT administered first
Group 2: NVPS-R administered first
Gender
Male
Female
Hispanic origin
Yes
No
Race
White
Black/African
Education
Primary
Secondary
Post Secondary
Bachelor
Master
American Society of Anesthesiologists
(ASA) Physical Status Classification System
1 Healthy patient
2 Mild Systemic Disease
3 Severe Systemic Disease
4 Incapacitating Systemic Disease
Pre op Analgesic/medications treatment
Yes
No
Pre op Analgesic/medications
Acetaminophen
Other pain med
No medication
Surgery Category
Abdominal-pelvic
Gastrointestinal
Gynecologic
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20 (50.0%)
20 (50.0%)
11 (27.5%)
29 (72.5%)
40 (100.0%)
0 (0.0%)
34 (85.0%)
6 (15.0%)
5 (12.5%)
21 (52.5%)
5 (12.5%)
6 (15.0%)
3 (7.5%)

4 (10.0%)
27 (67.5%)
8 (20.0%
1 (2.5%)
17 (42.5%)
23 (57.5%)
6.0 (15.0%)
13.0 (32.5%)
23.0 (57.5%)
7 (17.5%)
15 (37.5%)
18 (45%)

Characteristics
Primary Diagnoses
Uterine Myoma
Hernia
Gynecologic Carcinoma
Colon Carcinoma
Ureter Carcinoma
Other diagnoses
Cancer Diagnosis
Yes
No
Intraop Opioids*
Fentanyl
Morphine
Other

Total n (%)
5(12.5%)
5(12.5%)
10(25%)
6(15.0%)
1(2.5%)
13(32.5%)
17 (42.5%)
23(57.5%)
40 (100.0%)
21(52.5%)
0 (0.0%)

*Not mutually exclusive

The surgical categories for the participants included gynecologic surgeries (45%),
followed by gastrointestinal surgery (37.5%), and abdomino-pelvic surgery (17.5%). Many
participants had a cancer diagnosis (42.5%). Of all cancer diagnoses, the most prevalent was
gynecologic carcinoma (25%), with colon carcinoma being the second most frequent diagnosis
(15%), and ureter carcinoma (2.5%) the third. Other common primary diagnoses included uterine
myoma (12.5%), hernia (12.5%), and other diverse diagnoses (32.5%), including, Crohn’s
disease, ulcerative colitis, enteric fistula, cystocele, intestinal obstruction, spleen cyst, pelvic
mass, left upper quadrant mass, and vesicovaginal fistula.
The use of pre-operative opioid and non-opioid medication(s) for pain management, one
day before surgery, was reported by 42.5% of participants. The primary non-opioid medication
used alone was acetaminophen by 15% of participants. Other non-opioid medications given
include, gabapentin 10%, and aspirin 2.5%, which accounted for another 12.5% of the
participants who received medication pre-operatively. As for the pre- operative opioid
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medication, 7.5% of the patients received morphine, 5% received tramadol, and 2.5% were given
ultracet, which accounted for another 15% of the participants who received medication.
Intraoperative pain management included opioid administration, specifically fentanyl that was
administered to 100% of participants. Morphine was administered intraoperatively; closest to
the end of the surgery, to 52.5% of participants.
Pre-operative vital signs measurements of heart rate (HR), mean arterial pressure (MAP),
respiratory rate (RR) and pulse oxygen saturation (SpO2) were recorded and averaged, patients
reported a HR of 78.3 +16.6 beats/mins, MAP of 97.3+13.6mmHG, SpO2 99.5 ± 0.8%, and RR
17.7 ± 2.3 R/min.
Pain intensity was assessed using the numeric rating scale (NRS) prior to surgery, to
establish a baseline measurement of pain. The NRS is a gold standard instrument used to
measure pain intensity in verbal patients (Dhile, 2006). NRS scale intensity varies from 0 (no
pain) to 10 (maximum pain intensity). Participants reported a pain intensity mean of 3.2 ± 3.4.
On average, the intraoperative duration of general anesthesia in the patients of this study was
9.86 ± 2.38 hours (mean± SD).
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Table 2. Characteristics of Study Participants for continuous variables, n=40
Characteristics

Mean (SD)

Continuous variables
Age

Range

49.3 (17.1)
22.0-87.0
Weight (kgs)
79.8 (29.4)
38.6-167.7
Pre-op Heart Rate (HR), l/min
78.3 (16.6)
55.0-120.0
Pre-op Mean Arterial Pressure (MAP), mmHg
97.3 (13.6)
68-124.3
Pre-op Oxygen Saturation (SpO2), %
99.5 (0.8)
97.0-100.0
Pre-op Respiratory Rate (RR), r/min
17.7 (2.3)
12.0-22.0
Pre-op Pain Score Numeric Rating Scale (NRS) (0-10)
3.2 (3.4)
0.0-10.0
Anesthesia Time (in hours)
9.86 (2.38)
7-15.25
Results: Analyses of Randomization (“Order Effect”)
Randomization yielded groups that were similar with regards to demographics and
surgical experience, see Appendix Table 3. The Fisher Exact test and Mann-Whitney tests were
each performed for the CPOT and NVPS-R. With the exception of the primary diagnosis,
gynecologic carcinoma, no statistically differences were observed. There was a higher number of
patients diagnosed with gynecologic carcinoma (n=9) in the group where the CPOT was
administered first (p=0.008). However, when the demographic profile and characteristics for
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discrete and continuous variables between the two groups were evaluated, the randomization of
the two groups was similar and there were no significant differences (p-value≥0.05) in the
distribution of the two groups.
Analyses of Study Aims
Results Aim 1
The first aim was to describe the relationship between pain scores obtained using the
NVPS-R and CPOT assessment tools, when administered upon arrival (time 0) to the PACU,
among patients undergoing major abdominal, pelvic, or gastrointestinal surgery. We assessed
this relationship using a scatter plot, Pearson’s correlation and a simple linear regression model
at baseline (time 0) with a 95% Confidence Interval (CI). Results from the Pearson’s correlation
for Aim 1 (Figure 2) showed that the CPOT and NVPS-R pain scores were positively correlated
(correlation coeffcient, r= 0.88). The final prediction equation was NVPS-R_0 = 0.3345383 +
0.8081036*CPOT_0, meaning that for each one-point increase in CPOT at time 0, NVPS-R at
time 0 increased by 0.81. Results showed that the two-tail p-values were statistically significant
(p-value ≤0.05). In other words, CPOT at time 0 was statistically significant in explaining
NVPS-R at time 0.
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Figure 2. Scatter plot of CPOT at time 0 vs. NVPS-R at time 0
(The size of the dot visually represents the amount of possible (x,y) pairs in the same coordinate.
The bigger the dot the more cases that reported the same scores on both scales).
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Figure 3. Scatter Plot of CPOT at time 120 vs. NVPS-R at time 120
(The size of the dot visually represents the amount of possible (x,y) pairs in the same coordinate. The bigger
the dot the more cases that reported the same scores on both scales

Results Aim 3
To describe the change in pain scores over time obtained using the NVPS-R assessment
tool following arrival to the PACU at the following time points 0, 15, 30, 45, 60, 90 and 120
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minutes. We created a table to evaluate the means, standard deviations (SD) and range of each
time point values of NVPS-R (Table 3).
Table 3: Mean and Range of NVPS-R Scores at Different Times (in minutes)
Mean ± SD
Time (minutes)
Range (max - min)
0
2.37 ± 1.89
6–0
15
2.55 ± 1.55
7–0
30
2.49 ± 1.50
7–0
45
2.55 ± 1.67
6–0
60
2.11 ± 1.63
6–0
90
2.12 ± 1.60
6–0
120
1.75 ± 1.73
6–0
Figure 4 depicts the values for the means of NVPS-R pain scores over time. Results of
the average NVPS-R scores showed that for all subjects the scores remained more or less
constant during the first 45 minutes and gradually decrease (Figure 4).
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Figure 4. NVPS –R Mean Average Scores Over Time
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Results Aim 4
To describe the change in pain scores over time obtained using the CPOT assessment tool
at the following time points (minutes) following arrival to the PACU: 0, 15, 30, 45, 60, 90 and
120, we created a table in order to evaluate the mean, standard deviation (SD) and range of each
time point values for CPOT (Table 4).
Table 4: Mean and Range of CPOT Scores at Different Times (in minutes)
Mean ± SD
Time Points (minutes)
Range (max - min)
0
2.55± 2.06
7–0
15
2.87± 1.74
7–0
30
2.70 ± 1.71
6–0
45
2.66 ± 1.76
6–0
60
2.28 ± 1.81
6–0
90
2.03 ± 1.51
6–0
120
1.71 ± 1.78
6-0

Figure 5 depicts the values for CPOT mean pain scores over time. Results of the average
CPOT pain scores showed an increase in the first 15 minutes, where afterwards they seem to be
slowly decreased (Figure 5).
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Figure 5. CPOT Average Scores Over Time
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Figures 6 and 7 show each patient’s NVPS-R and CPOT scores, respectively over time.
Overall, both graphs resulted in different patterns when examining change in pain scores over
time for each individual patient.

Figure 6. NVPS-R Scores over time for each patient

Figure 7. CPOT Scores Over Time for each patient

Figure 8 show repeated measures used to compare changes in pain scores over time using
the NVPS-R and CPOT across the seven time points for all 40 subjects from arrival to the end of
early postoperative period at PACU. A total of 246 repeated measures were achieved among the
patients with each instrument.
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Overall, a comparison over time between NVPS-R total scores and CPOT total scores showed
total pain scores correlations between instruments at each time point and doses of pain
medication doses administration across time points.

Figure 8: CPOT and NVPS-R total scores profile comparison
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Comparison of CPOT and NVPS-R Scores Plots at Different Times
Figure 9 shows pain assessment scores using CPOT and NVPS-R scales at six time
points; 0, 30, 45, 60, 90, and 120 (minutes), had similar mean pain scores. It was noted that at
most times there were no differences with the administration of one or another instrument,
except for the measurements taken during time 15 (minutes) upon arrival to the PACU (Table 4).
The plot, at this time point, showed a slight increase in CPOT mean score (mean/SE 2.87 ±
1.74) when compared with the NVPS-R mean score (mean/SE 2.55 ± 1.55) (Table 3). The pvalue showed a statistically significant difference (p≤ 0.05) at this time point (15 minutes).

Figure 9. Comparison of CPOT vs NVPS-R Scores Plots at Different Time points
Results Aim 5
To address aim 5 we performed a Wilcoxon Signed Rank test analysis (Table 5) to
describe if the change over time between the CPOT and NVPS assessment tool was the same or
not. For this assessment the changes from 0 to 120, 0 to 15, 15 to 30, 15 to 45, 15 to 60, and 15120 minutes were calculated because they are clinically important points.
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Table 5: Summary p-values for changes in different time points
Time differences (minutes) among CPOT
and NVPS-R
0-120

P value*
0.3558

0-15

0.2270

15-30

0.7767

15-45

0.1558

15-60

0.2132

15-120

0.0496

*p values were obtained using Wilcoxon Signed Rank analysis

Change over time from time 0 min to 120 minutes
For this difference (scores at 120 min – scores at 0 min) only 24 patients were used for
the analysis because the other 16 patients were awake at time 120 (minutes). There is no
statistically significant difference between the score change of CPOT from time 0 to time 120
and the change of NVPS from time 0 to time 120.
Prob > |z| = 0.3558.
Change in time from time 0 min to time 15 mins
There are no statistically significant differences between the change of CPOT from time 0 to 15
minutes and NVPS from time 0 to 15 minutes.
Prob > |z| = 0.2270
Change in time from time 15 min to time 30 mins
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There are no statistically significant differences between the change of CPOT from time 15 to 30
minutes and NVPS from time 15 to 30 minutes.
Prob > |z| = 0.7767

Change in time from time 15 minutes to time 45 minutes
There are no statistically significant differences between the change of CPOT from time 15 to 45
minutes and NVPS from time 15 to 45 minutes.
Prob > |z| = 0.1558
Change in time from time 15 min to time 60 mins
There are no statistically significant differences between the change of CPOT from time 15 to 60
minutes and NVPS from time 15 to 60 minutes.
Prob > |z| = 0.2132
Change in time from time 15 min to time 120 mins
For this difference (scores at 120 min – scores at 15 min) there were
statistically significant differences between the score change of CPOT from time 15 to 120
minutes and the score change in NVPS from time 15 to 120 minutes.
Prob > |z| = 0.0496.
Ancillary Analyses: Relationship of CPOT and NVPS-R Scores to Vital Signs
In ancillary analyses, the relationship between CPOT and NVPS-R was investigated at
three different time points with selected physiologic parameters (vital signs and respiratory):
heart rate (HR), mean arterial pressure (MAP), respiratory rate (RR), and oxygen saturation
(SpO2). The three time points include time 0 at arrival to the PACU, time 15 after arrival to the
PACU which was one important time point in behavioral pain scores differences between
instruments, and at 120 minutes the end of early postoperative period.
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For these analyses, three (3) groups of patients were hypothesized a priori as clinically
distinct: Group A) CPOT total ≤2 and NVPS total ≤2; Group B) CPOT total ≥3 or NVPS total
≥3; and Group C) CPOT total ≥3 and NVPS total ≥3. Patients were grouped using these criteria
at each time point.
Vital signs at baseline (time 0)
Table 6 shows means and standard deviations for each vital sign at time 0 for all 40
participants, by groups A (n=23), B (n=3), and C (n=14). Results show an average heart rate
(HR) of 79 beats (b)/min for group A, 97 b/min for group B, and 85 b/min for group C. In Group
A, patients with no significant pain showed a lower average HR (79.0 ± 12.5 b/min) than those
patients in Group B with significant pain on the CPOT or NVPS-R scale (97.0 ±6.2), or those
patients in Group C with significant pain in both CPOT and NVPS-R scales (85.4 ±19.8).
The mean of the mean arterial pressure (MAP) was 93.7 mmHg for Group A, 100.0
mmHg for group B, 95.3 mmHg for group C. The MAP results showed that patients in Group A,
without significant pain, presented a lower average MAP (93.7 ± 12.2 mmHg) than those
patients in Group B, who had one assessment of significant pain on the CPOT or NVPS-R scale
(100.3 ± 33.7). However, those patients in Group C, who had significant pain in both CPOT and
NVPS-R scales, presented an average MAP of 95.3 ± 13.1 between the three groups (A,B, and
C).
In the Group A, the average oxygen saturation (SpO2) was (99.2 ± 1.3) %, in Group B it
was (100 ± 0.0) %, and in Group C it was (98.1 ± 2.6) %. The average SpO2 between patients
without significant pain, those in the Group A, and with significant pain, those in Groups B and
C, was very similar.
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Respiratory rate (RR) for Group A was (17.6± 5) R/min, for Group B it was (18.3 + 0.6)
R/min, and for Group C it was (17.8 ± 7.7) R/min. The RR among patients in Group A, B and C,
generally maintained within the same average level.
Table 6: Summary Statistics of Vital Signs and CPOT and NVPS-R Assessments Meeting Clinical
Threshold of Pain: Time 0
Time 0
Group A: Both
Group B: Exactly one
Group C: Both
CPOT total <2 and
of CPOT total >3 and
NVPS-R total <2
CPOT total >3 or
NVPS-R total >3
NVPS-R total >3
n=23
n=3
n=14
Number, n
Heart Rate,b/min
Mean (sd)
79.0 (12.5)
97.0 (6.2)
85.4 (19.8)
Range
60-113
90-102
56-102
MAP, mmHg
Mean (sd)
93.7 (12.2)
100.3 (33.7)
95.3 (13.1)
Range
73.0-117.7
68-135.3
68.7-119
SPO2, %
Mean (sd)
99.2 (1.3)
100.0 (0.0)
98.1 (2.6)
Range
95-100
100-100
92.0-100
RR, r/min
Mean (sd)
17.6 (5.0)
18.3 (0.6)
17.8 (7.7)
Range
9-28
18-19
9-36

Group differences in vital signs at time 0 were tested for significance using the Kruskal-Wallis
test (Table 7). No statistically significant differences were observed.

Table 7: Kruskal-Wallis of Vital Signs by groups of CPOT and NVPS-R Assessments Meeting
Clinical Threshold of Pain at time 0 minutes
Time 0 min
Chi-square
P value
Heart Rate, l/min
4.444
0.108
MAP, mmHg
0.631
0.886
SPO2, %
1.227
0.208
RR, r/min
0.846
0.737

65

Vital signs at time 15 (minutes)
Table 8 shows means and standard deviations for each vital sign at time 15, separately for
groups A (n=14), B (n=6), and C (n=20). Results showed an average heart rate (HR) of
73.1±12.3 for Group A (n=14), 90.1 + 0.0 for Group B (n=6), and 78.4 + 18.3 for Group C
(n=20). The HR among Groups A, B and C showed a mean increase.
In Group A, patients with no significant pain showed a lower average HR (73.1±12.3
b/min) than those patients in Group B with significant pain on the CPOT or NVPS-R scale (90.1 +
0.0),

or those patients in Group C with significant pain in both CPOT and NVPS-R scales (78.4 +

18.3).

The mean of the mean arterial pressure (MAP) was 93.5 mmHg for Group A, 100.0
mmHg for group B, 93.8 mmHg for group C. The MAP results showed that patients in Group A,
without significant pain, presented a lower average MAP (93.5 ± 11.4 mmHg) than those
patients in Group B, who had one assessment of significant pain on the CPOT or NVPS-R scale
(100 ± 13.9). However, those patients in Group C, who had significant pain in both CPOT and
NVPS-R scales, presented an MAP of 93.8 ± 15.2, similar to the patients withouth significant
pain in group A.
In the Group A, the average oxygen saturation (SpO2) was (99.7 ± 0.47) %, in Group B it
was (99.8 ± 0.41) %, and in Group C it was (99.5 ± 0.82) %. The average SpO2 among patients
in Group A, B and C was similar.
Respiratory rate (RR) for Group A was (18.6± 1.7) R/min, for Group B it was (17.3 +
3.0) R/min, and for Group C it was (17.6 ± 2.5) R/min. The RR among patients in Group A, B
and C, generally was maintained in the same average level.
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Table 8: Summary Statistics of Vital Signs and CPOT and NVPS-R Assessments Meeting
Clinical Threshold of Pain: Time 15
Time 15
Group A: Both
Group B: Exactly one
Group C: Both
CPOT total <2 and
of CPOT total >3 and
NVPS-R total <2
CPOT total >3 or
NVPS-R total >3
NVPS-R total >3
n=14
n=6
n=20
Number, n
Heart Rate,b/min
Mean (sd)
73.1 (12.3)
90.1 (00.0)
78.4 (18.3)
Range
60-99
63-106
55-120
MAP, mmHg
Mean (sd)
93.5 (11.4)
100 (13.9)
93.8 (15.2)
Range
73-111
85-123
67.3-122.6
SPO2, %
Mean (sd)
99.7 (0.47)
99.8 (0.41)
99.5 (0.82)
Range
99-100
99-100
98.0-100
RR, r/min
Mean (sd)
18.1 (1.7)
17.3 (3.0)
17.6 (2.5)
Range
14-20
12-20
12-22
Group differences in vital signs at time 15 were tested for significance using the
Kruskal-Wallis Test (Table 9). No statistically significant differences were observed.
Table 9: Kruskal Wallis of vital signs by groups of CPOT and NVPS-R assessments meeting
clinical threshold of pain at time 15 minutes
Time 15 min
Heart Rate, l/min

Chi-square
4.18

MAP, mmHg
SPO2, %

0.83
0.61

RR, r/min

0.41

P value
0.12
0.66
0.73
0.81

Vital signs at time 120
Table 10 shows means and standard deviations for each vital sign at time 120, separately
for groups A (n=16), B (n=4), and C (n=4). Results showed an average heart rate (HR) of
76.9±15.7 for Group A (n=16), 85.5 + 25.1 for Group B (n=4), and 76.0 + 9.6 for Group C
(n=4). The HR among Groups A, B and C showed a mean decrease.
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The average MAP for Group A was 94.6± 11.6 mmHg, for the Group B it was 104.7 ±
7.7 mmHg, and for Group C was 93.9 ±19.2 mmHg. There was a slight increase, approximately
of 10.1 mmHg, in the average MAP of participants in the Group B. On the other hand, there was
a slight decrease, approximately of 0.7 mmHg, in the average MAP in the Group C when
compared with the average MAP of Group A. See Table 10.

Table 10: Summary Statistics of vital sign by groups of CPOT and NVPS-R assessments
meeting clinical threshold of pain at time 120 minutes
Time 120 min
Group A: Both
Group B: Exactly
Group C: Both
CPOT total ≤2 and one of CPOT total
CPOT total ≥3 and
NVPS-R total ≤2
≥3 or NVPS-R
NVPS-R total ≥3
total ≥3
Number, n
16
4
4
Heart Rate, l/min
Mean (sd)
Range
MAP, mmHg

76.9 (15.7)
53-110

85.5 (25.1)
58-115

76.0 (9.6)
66-88

Mean (sd)
Range
SPO2, %

94.6 (11.6)
69.7-112.7

104.7 (7.7)
97.3-112

93.9 (19.2)
66.3-109.3

Mean (sd)
Range
RR, r/min

99.7 (0.6)
98-100

100 (0)
100-100

97.7 (3.9)
92-100

Mean (sd)
Range

17.1 (4.74)
8-27

13.7 (3.9)
10-18

20.0 (4.0)
18-26

The average oxygen saturation (SpO2) for Group A was 99.7 ± 11.6%, for Group B it was
100 ±0.0 %, and for Group C it was 97.7 ± 3.9%. In addition, the average RR for Group A was
17.0 ± 4.7 R/min, for Group B it was 13.7 ± 3.9 R/min, and for Group C it was 20 ± 4.0 R/min.
There was a slight decrease approximately of 3.4 R/min, in the mean RR of participants in the
Group B when compared with Group A. On the other hand, there was a slight increase in the
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average RR, approximately of 6.3 R/min, in the Group C when compared with Group B.
Group differences in vital signs at time 120 were tested for significance using the
Kruskal-Wallis Test (Table 11). No statistically significant differences were observed.

Table 11: Kruskal Wallis of vital signs by groups of CPOT and NVPS-R assessments meeting
clinical threshold of pain at time 120 minutes
Time 120 min
Heart Rate, l/min

Chi-square

P value

0.338

0.845

2.256

0.324

1.634

0.442

3.729

0.155

MAP, mmHg
SPO2, %
RR, r/min

Incidental finding: Significant pain and relationships in changes for vocalization indicator
for CPOT, and Physiologic I, and respiratory indicators for NVPS-R
Table 12 shows the frequency of patients with significant pain that showed a CPOT
vocalization indicator ≥1, and NVPS-R physiologic I, and respiratory indicators ≥1.
It was found that over 70% of patients with significant pain across time points scored >1
on the CPOT vocalization indicator, while less than 70% scored >1 on the physiologic indicator
of the NVPS-R and less than 30% scored >1 on the NVPS respiratory indicator.
Also was also found that more patients with significant pain (NVPS-R or CPOT >3) or
the NVPS-R (n=20) and CPOT (n=22) at time 15 (minutes) than for patients with a total score
indicative of significant pain at the other time points. At time 15 were found in the indicators; for
CPOT in vocalization and for NVPS-R in the physiologic I indicators. For the CPOT
vocalization indicator, increases were shown in the partial score where 86% of patients (n=19)
had significant pain at this time point and presented increases in vocalization. For NVPS-R
physiologic indicator I, the total quantity of patients that showed increases in partial score was
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(n= 4) which indicates that 20% of patients with significant pain at this time point presented
physiologic I (MAP) increase. The same quantity of patients (n=6) presented significant pain at
time 120 with both scales during assessment.

Table 12. Patients with significant pain that showed vocalization, physiologic I, and respiratory
indicators ≥1
CPOT
NVPS-R
Time points
CPOT
Vocalization
NVPS-R Physiologic I ≥1
Respiratory
(minutes)
≥3*
≥1
≥ 3*
frequency (%)
≥1
freq.
frequency (%)
freq.
frequency (%)
16
14 (88%)
15
5 (33%)
2 (13%)
0
22
19 (86%)
20
5 (25%)
0 (0%)
15
19
18 (95%)
15
7 (47%)
2 (13%)
30
19
14 (74%)
17
4 (24%)
2 (12%)
45
15
12 (80%)
12
3 (25%)
0 (0%)
60
10
9 (90%)
11
6 (55%)
3 (27%)
90
6
6 (100%)
6
4 (67%)
0 (0%)
120
*Total patients with significant pain per time points using CPOT and NVPS-R,

Summary
The use of two behavioral acute pain assessment instruments simultaneously in this study
provided important information about the relationships between instruments to enhance
anticipatory assessment and management of pain in the early post operative period. A goal is to
recommend one of the instruments for the early pain assessment in PACU, based on comparisons
and results.
For this study a total of fifty- nine patients, 22 to 87 years of age were initially consented.
Of these, 19 subjects were excluded. The final sample was comprised of 40 subjects, who were
divided into two groups. Group one included 20 participants that were assessed first with the
CPOT and with the NVPS-R second. Group two consisted of 20 participants who were assessed
with the NVPS-R tool first and with the CPOT second.
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To assess the potential for selection bias the adequacy of randomization was evaluated.
Randomization yielded groups that were similar with regards to demographics and surgical
experience. Fisher’s Exact test and Mann-Whitney tests were performed one for CPOT and one
for NVPS. With the exception of the primary diagnosis gynecologic carcinoma, no statistically
significant differences were observed. There was a higher number of patients diagnosed with
gynecologic carcinoma (n=9) in the group where the CPOT was administered first (p=0.008).
However, the demographic profile and characteristics for discrete and continuous variables
between the two groups was evaluated and there were no significant differences (p-value≥0.05)
in the distribution of the two groups.
The socio-demographic data showed the average age of the participants was 42.5 years
with the youngest being 22 and the oldest being 87. Over half (52.5%) of the participants had
achieved secondary school education. Most participants were ASA 1 and ASA 2 from the ASA
physical status classification system, and only 10.0% of the patients were healthy (ASA 1) and
67.5% had a mild systemic disease (ASA 2). ). The majority of participants, 72.5%, were
female, about 85% were white and 100% were of Hispanic origin.
The surgical categories included 45% gynecologic surgeries, followed by 37.5%
gastrointestinal surgery, and 17.5% abdominal-pelvic surgery. Most of the participants had a
cancer diagnosis (42.5%); 25% of these were diagnosed with gynecologic carcinoma 15% with
colon carcinoma, and 15% with ureter carcinoma.
In terms of study aims a linear relationship was evaluated between CPOT and NVPS-R
tool pain scores through a scatter plot using Pearson’s correlation at time 0 (baseline) with a 95%
CI. Results showed a positive correlation between CPOT and NVPS-R tool pain scores (r= 0.88;
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p≤0.05). Results showed the two-tail p-values were statistically significant (p-value ≤0.05). In
other words, CPOT at time 0 was statistically significant in explaining NVPS at time 0.
The linear relationship between CPOT and NVPS-R tool pain scores were evaluated at
120 minutes through a scatter plot with a 95% CI. Results showed CPOT and NVPS-R tool pain
scores were positively correlated (r= 0.89; p-value≤0.05). Results showed CPOT at 120 minutes
explained 80% of the variation in NVPS-R at time 120 minutes and the two-tail p-values were
statistically significant (p-value ≤0.05). NVPS-R results showed that for all subjects, on average,
the score remained more or less constant during the first 45 minutes and then gradually
decreased. Additionally, CPOT results showed that for all subjects, on average, CPOT pain score
increased in the first 15 minutes where afterwards they slowly decreased.
Overall, mean pain assessment scores using CPOT and NVPS-R scales at six time points,
0, 30, 45, 60, 90, and 120 minutes, were similar. It was noted that most times there were no
differences with the administration of one or another instrument, except for the measurements
taken during time 15 (minutes) upon arrival to the PACU (Table 4). The plot (Figure 4), at this
time point, showed a higher CPOT mean score (mean/SE 2.87 ± 1.74) in comparison with the
NVPS-R (mean/SE 2.55 ± 1.55). The p-value showed a statistically significant difference
between scores (p≤ 0.05) at time 15 minutes. Overall the NVPS-R and CPOT score over time,
resulted in different patterns changes among patients.
To describe the relationship between the change over time in pain scores obtained using
the CPOT assessment tool and the NVPS-R assessment tool paired t-tests were performed. Time
changes from 0 to 120, 0 to 15, 15 to 30, 15 to 45, 15 to 60, and 15-120 minutes seen as
clinically important time points, were evaluated. No statistically significant difference was
observed between the change in CPOT scores from time 0 to 120 minutes and the change in the
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NVPS scores from time 0 to 120 minutes. The differences from time 0 to 15 minutes and from
time 15 to 60 minutes also were not significant. Meanwhile, there was a statistically significant
difference between the CPOT change scores from time 15 to 120 minutes and the NVPS-R
change scores from time 15 to 120 minutes.
In ancillary analyses, at each time point, we investigated the relationship between CPOT
and NVPS-R with selected vital signs: heart rate (HR), mean arterial pressure (MAP),
respiratory rate (RR), and oxygen saturation (SpO2). A Kruskal-Wallis test was conducted at
time zero and we observed no statistical differences (p-value>0.05) between the pain scores and
the different categories of each vital sign (i.e. HR, MAP, RR, and SpO2). Likewise, at 15 and
120 minutes, we observed no statistical differences (p-value>0.05) between the pain scores and
the different categories of each vital sign (i.e. HR, MAP, RR, and SpO2).
With the exception of time point 15 minutes, and NVPS-R vital signs indicator, most of
the statistical tests showed that both scales were significantly related at different time points.
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CHAPTER 5
DISCUSSION
Introduction
Acute pain is an expected physiologic experience to noxious stimuli, and motivates
behaviors (Hadjistavropoulos et al., 2011), such as in post-surgical patients. In 2010, 51.4
million Americans underwent a surgical procedure(s) (National Center for Health Statistics,
2010). Several studies provide evidence that more than 75% of surgical patients report pain after
surgery (Gramke et al., 2007; Apfelbaum, Chen, Mehta, & Gan, 2003; Warfield & Khan, 1995).
The most important clinical approach to ensure effective pain management is to perform an
optimal pain assessment. Currently, the Numeric Rating Scale (NRS) is the gold standard
instrument used to assess pain among verbal patients who can self report pain (Downie et
al.,1978). However, in the early postoperative period, it is believed that the residual effects of
general anesthesia and sedative medication interfere with cognitive functions, which often makes
it difficult for patients to verbally self-report their pain (Chou et al., 2016). Furthermore, the use
of sedation does not equate to an absence of pain or pain relief (Herr, Coyne, McCaffery,
Manworren, & Merkel, 2011). During the early post-operative period the use of objective pain
assessment instruments is the key to adequate pain management. Observation of behavior is a
valid approach for pain assessment in the absence of self-report.
This chapter will discuss findings of the study on acute pain assessment in nonverbal
sedated patients conducted in a teaching hospital in San Juan, Puerto Rico. Recently the APS
panel provided a strong recommendation for the use of validated assessment tools on
postoperative pain assessment. Although there is inadequate evidence, this study provided data
for two selected behavioral instruments, CPOT and NVPS-R. These instruments, which measure
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similar behavioral indicators, were selected because they were validated in other populations.
The exception between instruments includes, for CPOT vocalization indicator and for
NVPS-R physiological and respiratory indicators. The interpretations were based on
investigator analysis and interpretation of these findings. Additionally, this chapter will discuss
the limitations of the study, strengths, future research focus, and the implications for nursing
practice.
Characteristics of study participants
This study included a patient population of forty participants; the majority were females,
with mild systemic disease. The participants required abdomino-pelvic, gynecologic or
gastrointestinal surgery, and general anesthesia. Prior to surgery, patients were assessed for pain
intensity with the NRS. The NRS categorizes pain intensity on a scale of 0 to 10: no pain (0),
mild (1-3), moderate (4-6), to severe (7-10)(Dihle, Helseth, Kongsgaard, Paul, & Miaskowski,
2006). This assessment was fundamental to establish that patients were not experiencing severe
or chronic pain before the surgical procedure, because it could have an effect on physiological
indicators and lead to persistent pain in the PACU. Findings indicated that the overall baseline
preoperative pain intensity in patients was 3.2 (i.e. mild). Surgery is an expected triggering factor
for acute pain in all patients. Patients arrive at the post anesthesia care unit (PACU) with an
expected presence of acute pain due to surgery, yet pain cannot be self-reported by some because
they arrive to the PACU in a nonverbal state due to sedation levels.
Two nonverbal pain instruments (NVPS-R and CPOT) were used to assess the presence
of pain and evaluate the relationship between the two instruments, in order to recommend one to
assess acute pain in nonverbal sedated patients in the PACU. Each instrument includes measures
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of pain behaviors, defined as indicators in the CPOT and categories in the NVPS-R (Table 13).
The CPOT has four indicators: facial expression, body movements, muscle tension, and
vocalization for non-intubated patients. The NVPS-R is comprised of five categories: face,
activity, guarding, physiological I (vital signs: blood pressure and heart rate), and respiratory
(respiratory rate and SpO2). Differences between scales include the two physiological categories
(vital signs and respiratory) included in the NVPS-R and the vocalization indicator included in
the CPOT.
Table 13. Comparison of CPOT Behavioral Indicators vs. NVPS-R
CPOT indicators
NVPS-R categories
Similarities
Facial expression
Face
Body movements

Activity

Muscle tension

Guarding
Differences

Vocalization
(non-intubated patients)

Physiological I vital signs
(blood pressure, heart rate)
Respiratory
(respiratory rate and SpO2)

Relationships between pain instruments at time 0 and time 120
At time 0 minutes, pain was measured in sedated patients after surgery, using the total
pain score from each patient to assess whether or not there were differences in pain scores
between the instruments. A high positive correlation was observed, meaning that both
instruments determined pain presence in the population of this study. Other studies with sedated,
critical care patients (Cade, 2008; Kabes, Graves, & Norris, 2009) have found inter-rater and
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behavior indicator reliability, which supports the observed correlation of pain behavior indicators
found between CPOT and NVPS-R in this study.
When assessing the linear relationship between both instrument’s pain scores at 120
minutes and the total pain scores, a strong positive correlation was found showing similarities
between both instruments in behavioral indicators or categories. At time 120 minutes after arrival
at PACU, pain was measured in sedated patients using the pain total score for each patient to
assess whether or not there were differences in the recording of pain scores between the two
instruments. In the study, CPOT explained 80% of the variation in the NVPS and a relationship
exists between the two instruments to indicate pain presence.
Change in pain scores over time points in each instrument individually and between both
instruments
Patients change in pain scores over time was obtained using the NVPS-R following
arrival to the PACU at seven time points 0, 15, 30, 45, 60, 90 and 120 minutes. Because there is
insufficient evidence to guide final recommendations on optimal timing or frequency of patient
reassessments in the postoperative setting (Chou et al., 2016), the time points used in this study
coincided with the established protocol for vital sign measurement in the PACU.
NVPS-R results showed, for all patients on average, an increased score in the first 15
minutes, which remained fairly constant up to the 45-minute time point, where it slowly
decreased until 120 minutes. This assessment also was conducted using the CPOT at the same
time points following arrival to PACU. CPOT mean score results showed that, on average, pain
score increased in the first 15 minutes, whereas it slowly decreased from then on.
The results showed that the pain assessment scores using CPOT and NVPS-R at six of
the seven time points; 0, 30, 45, 60, 90, and 120 minutes had a similar mean. It was noted that
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there were no differences with the administration of either instrument; except for the
measurements taken at the 15 minutes time point, after arrival to the PACU. At this time point,
there was an increase in CPOT mean score in comparison with the NVPS-R. There was an
increase in the frequency of vocalization indicator used only in the CPOT, which is one of the
differences between both instruments. One reason for this change at this time point is that
patients’ sedation levels were between low to moderate (RASS -2, -3), and some patients were
able to vocalize with sighs, moans, cries and/or sob behaviors, for example.
Repeated measures were used to compare changes in pain scores over time using the
NVPS-R and CPOT across the seven time points from arrival to the PACU at time 0,15, 30, 45,
60, 90, and 120 minutes. Every patient had three to seven pain assessment measures. Thus, a
total of 246 repeated measures were achieved among the forty patients with each instrument.
When NVPS-R and CPOT scores were compared over time, different patterns resulted among
patients. The comparison of repeated patient measures resulted in a single graph, where a
specific pattern was not shown. These results reinforce the conclusion of several authors that
more information is needed about the large individual variability in pain experience after surgical
procedures (Lundblad, Kreicbergs, & Jansson, 2008; Werner, Duun, & Kehlet, 2004; Turk &
Okifuji, 1999). In a clinical scenario, when assessing and managing pain, it is imperative to
remember that every patient’s pain experience is unique and individual.
In 1994 the International Association for the Study of Pain (IASP) stated that inability to
communicate verbally does not negate the possibility that an individual is experiencing pain and
is in need of appropriate pain-relieving treatment (International Association for the Study of
Pain, 1994). Health care providers need to use objective criteria to assess individual patient
behaviors to assess pain in nonverbal patients. Measures of pain assessment in non-verbal
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patients must include an interplay of objective and subjective assessment components. The
objective component includes observations made by nurses and healthcare providers through
reliable instruments related with complex patients behaviors, which are individual and subjective
in nature.
The symptom management theory (SMT) framework model used for this study helps us
conceptualize relationships between symptom components (acute pain) to describe, predict, and
explain the pain phenomena within the framework of nursing practice. The model focuses on
three dimensions: symptom experience, symptom management strategies, and outcome/symptom
status (Dood et al., 2001). The complexity of acute pain phenomena can be explained with the
SMT framework because patient needs can be conceptualized while understanding why different
patients pain behaviors were shown in nonlinear patterns. Each patient experiencing acute pain
showed behaviors that are not totally predictable, but their behaviors are interconnected.
Individual variability explains unpredictability and different acute pain patterns between patients.
To adequately assess and manage patient’s pain, nurses and healthcare providers need to accept
and work with this complexity. Although pain is a subjective experience for patients, nurses and
healthcare providers have to assess pain in an objective method in patients that cannot selfreport pain. The SMT helps to understand and direct patient care considering individual
symptom particularities.
Patient’s pain was assessed to describe the relationship between the change in pain scores
over time obtained using the CPOT and the NVPS-R, at seven clinically important time points
following arrival to the PACU. Changes were measured at arrival and at discharge from PACU
(0-120 minutes), at arrival and the first minutes after general anesthesia (0-15 minutes), at the
first minutes after general anesthesia to the third time point (15-30 minutes), at the first minutes
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after general anesthesia to fourth time point (15-45 minutes), at the first minutes after general
anesthesia and at the first hour (15-60 minutes), and at first minutes after general anesthesia, and
at the end of early postoperative period (15-120 minutes).
There were no statistically significant differences between the changes in CPOT and the
changes in NVPS-R at time 0 to 120 minutes, at time 0 to time 15, at time 15 to 30 minutes, at
time 15 to 45 minutes, and at time 15 to 60 minutes. There was a difference between the change
in CPOT and NVPS-R at time 15 and 120 minutes. At the 15-120 minutes time points include; at
the 15 minute time point, the time after patient arrival to the PACU and is the time when patients
are generally waking from anesthesia making them more able to manifest and express pain
behaviors. By the 120 minutes time point, many patients had either been discharged or had
adequate pain management.
Ancillary analyses: Relationship of CPOT and NVPS-R scores to vital signs
In ancillary analyses at three different time points, the relationship between CPOT and
NVPS-R was investigated with selected physiologic parameters (vital signs and respiratory):
heart rate (HR), mean arterial pressure (MAP), respiratory rate (RR), and oxygen saturation
(SpO2).
Vital signs at baseline (Time 0)
Differences between pain scores and the different physiologic categories including vital
signs and respiratory (i.e. HR, MAP, RR, and SpO2) were not observed upon patient arrival to
the PACU. Patients in the significant pain group, who had a score ≥ 3, did not present an
increase in physiologic or respiratory criteria (SaO2) on the NVPS-R during pain assessment.
This agrees with the findings of Puntillo, Miaskowski, Kehrle, Stannard, Gleeson, & Nye (1997)
who stated that the absence of increased vital signs cannot be considered absence of pain. This
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finding is also supported by Kapoustina, Echegaray & Gélinas, (2014), who indicated that vital
signs might not be specific to pain. Arbour & Gélinas, 2010 conducted a study in 33 post-cardiac
surgical patients where the results indicated that increases in vital sign parameters could be
related to other physiologic processes. Physiologic indicators are not sensitive for assessed pain
(Foster, Yucha, Zuk, & Vojir, 2003; Gélinas & Johnston, 2007). Absence of a change in vital
signs does not indicate absence of pain.
Vital signs at Time 15
Differences between pain scores and the different physiologic categories including vital
signs and respiratory (i.e. HR, MAP, RR, and SpO2) were not observed at time 15 minutes after
non-verbal patients arrival to the PACU. Patients with significant pain (group C), did not present
an increase in physiologic or respiratory criteria (SaO2) on the NVPS-R during pain assessment.
This agrees with the findings of Puntillo, Miaskowski, Kehrle, Stannard, Gleeson, & Nye (1997),
who stated that the absence of increased vital signs cannot be considered absence of pain. This
finding also correlates with Kapoustina, Echegaray & Gélinas, (2014), who indicated that vital
signs might not be specific to pain. Arbour & Gélinas, 2010 conducted a study in 33 post-cardiac
surgical patients where the result indicate that increases in vital signs parameters could be related
to other physiologic processes. Physiologic indicators are not sensitive for assessed pain (Foster,
Yucha, Zuk, & Vojir, 2003; Gélinas & Johnston, 2007). Absence of a change in vital signs does
not indicate absence of pain. As results suggest, the differences observed at 15 minutes in
patients with significant pain do not show correlation with pain presence and changes in vital
signs.
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Vital signs at time 120
Similar to the baseline, we did not observe differences between the pain scores and the
different categories of each vital sign (i.e. HR, MAP, RR, and SpO2) at 120 minutes. Clinically,
this means that the presence of significant pain in the participants of this study was not consistent
with an increase in the mean of the HR, MAP, RR, and SpO2. Overall statistical and clinical
results show that patients with significant pain in this study did not present changes in
physiologic or respiratory parameters of the NVPS-R immediately. However, increases in vital
sign parameters are still considered a sign to begin further assessment of pain in non-verbal
adults by experts, as published in the recent guideline for the management of postoperative pain
of the Task Force of the American Pain Society and American Society of Regional Anesthesia
and Pain Medicine, and the American Society of Anesthesiologists’ Committee on Regional
Anesthesia, Executive Committee, and Administrative Council (Chou et al., 2016). Thus, our
results do not agree with current recommendations and indicate that further research is required
to reconcile these differences.
At this time point we did observe one clinically important finding in a small group (n=4)
of patients with significant pain on one of the instruments. When data were explored, two of the
four patients presented an increase in MAP (NVPS-R physiologic parameter). This increase is
itself clinically relevant because when those patients are tracked individually, significant pain
was found through one or both instruments at two previous time points, 45 and 90 minutes. Pain
medication administration was not registered during those time points in both cases. This finding
correlates with a previous study where the validity of behaviors and fluctuations in vital signs for
pain assessment in post-brain surgery adults (Kapoustina, Echegaray-Benites, & Gélinas, 2014)
was examined and it was concluded that vital signs may suggest the presence of pain, although
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their validity for such use is not standard.
NVPS-R and CPOT scores to vital signs overall findings
Most of the statistical tests show that both instruments are significantly related at
different time points with the exception of time 15 (minutes), in which the CPOT was marginally
significantly different from the NVPS-R. There is no correlation between physiologic indicators
(vital signs and SpO2) increase on the NVPS-R and the group of patients with significant pain, in
both CPOT and NVPS-R measures. The impact of pain on physiologic parameter one of the
NVPS-R was observed in two patients without medication administration and significant pain
measures in previous time periods. Physiologic indicators in the NVPS-R were less frequent in
identifying significant pain. In this study, it was found that the CPOT was more frequent in
determining the significant presence of pain due to the observational behavior categories (facial
expression, body movements, muscle tension, and vocalization) measured by the instrument.
Thus, this study finding agree with Chanques et al. 2014, who considered 30 critical care patients
conducting 258 paired assessments. They used the CPOT, BPS and NVPS-R instruments. The
psychometric properties’ findings suggested correlations for NVPS-R and CPOT behavioral
indicators, but not for NVPS-R physiological indicator.
A study from Marmo and Fowler (2010) compared the NVPS-R, the CPOT, and Faces,
Legs, Activity, Cry, Consolability (FLACC scale for children) pain instruments to determine
each instruments’ consistency and reliability. The study indicated that the CPOT was more
reliable when evaluating pain in post-operative open-heart surgery intubated patients than the
NVPS-R which included vital signs (Marmo & Fowler, 2010). Those results were consistent
with what was observed in the post-operative patient group in the study reported here , although
the patients in this study were not intubated. Additionally, the use of the NVPS-R and CPOT was
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implemented in a study with verbal and non-verbal critical care patients. The patients were
assessed before, during, and after painful and non-painful stimuli. Reliability of the CPOT
instrument is evidenced by the consistent increase in pain scores (Topolovec-Vranic et al., 2013).
In 2013, Gélinas, Barr, Puntillo, & Joffe described and analyzed the development and
psychometric properties of eight behavioral pain assessment tools available for use in nonverbal
critically ill adults. They concluded that the CPOT and BPS are considered the most valid and
reliable, according to the available evidence. This study supports the use of the CPOT
instrument, as suggested in our study.
Incidental finding: Significant pain and vocalization indicator for CPOT, and Physiologic I,
and respiratory indicators for NVPS-R

The main differences in the results between the two instruments was the vocalization
indicator of the CPOT because in patients with significant pain at all time points the vocalization
indicator was more frequent in comparison with the physiologic I and respiratory indicators of
NVPS-R.
When the overall data were explored to identify the possible reasons for the marginal
differences between the instruments’ indicators at different time points; especially at time points
15 and 120 minutes identified as clinically important time points, fewer patients demonstrated
significant pain on the NVPS-R and CPOT at time 120 minutes in comparison with time 15
minutes. Data for those patients with significant pain at time 120 minutes reveal differences
between the two scales. For the CPOT vocalization indicator, 100% (n= 6) of patients with
significant pain at this time point presented this behavior. For the NVPS-R physiologic indicator
I, 66% (n= 4), of patients with significant pain at this time point presented an increase in MAP.
Both comparisons at time 15 and at time 120 minutes suggest that the vocalization measure
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included in the CPOT is a better indicator of pain than the physiological indicators included in
the NVPS-R.
Study Strengths and Limitations
The findings of this study denote the pain assessment performed by a single nurse
investigator. The participants represent a Hispanic group of non-verbal sedated patients after
major gastrointestinal, abdominal-pelvic and gynecologic surgeries. However, this study cannot
generalize the experience of all patients receiving care from a nurse in a PACU at the Medical
Center of PR. The findings of this study add to the nursing knowledge base of caring and the
assessment and management of acute pain in the early postoperative period.
Strengths of this study include the researcher’s experience as a nurse anesthetist who has
knowledge about working with patients during and after general anesthesia, and patients with
acute pain after surgery. This was helpful while conducting pain measurements and interacting
with the nurses and patients in the study setting. Randomization was used to reduce the bias for
order effect. The study participants were assigned randomly to one group; at the end both groups
were homogenous in characteristics. The two objective instruments used for the assessment of
acute postoperative pain in the study were previously tested and validated in other non-verbal
patient populations.
Limitations to the study were present, and included the research procedure in which one
research investigator assessed patients with both NVPS-R and CPOT instruments while the
management of pain was the responsibility of the unit nurse in charge of patients. Pain
assessment in the PACU of the Medical Center is based mainly on patient’s self- report and the
misconceptions of healthcare providers to manage pain after the nurse investigator reported
behavioral pain assessment score was evident. This limitation made it difficult to manage pain
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based on the objective measures of the instrument, as there was a delay or absence of medication
administration after significant pain assessment was reported to PACU nurses by the
investigator.
The progressive attrition of patients along the study may have reduced the likelihood of
finding statistical differences. Another limitation of the study was the selection of patients with
specific types of surgeries (abdomino-pelvic, gynecologic, and gastrointestinal), thus limiting
the generazability of results to other populations with different characteristics or types of
surgery.
Implications for Nursing Practice
The major implication of this study for nursing practice is the clinically significant result
which suggests that physiologic indicators of the NVPS-R, such as heart rate, mean arterial
pressure, respiratory rate and oxygen saturation, are not consistent parameters for assessment of
acute pain because in this study they did not show an immediate increase in patients with
significant pain. These results are consistent with current literature that further stresses that vital
signs should not be sole indicators for the presence of acute pain.
Using a valid, reliable, and feasible pain instrument (Wysong, 2014) is important when
assessing pain in postoperative patients in the early postoperative period by the nurse and other
health care providers. More studies are needed to establish new methods for communication
between healthcare providers and patients who are unable to self-report pain. Sedation level that
inhibits the possibility of self-report should not be a barrier for early assessment of acute pain.
Implications for Future Research
Although this area needs further study, the major contribution of this study to nursing
knowledge was the consistency of the CPOT vocalization indicator for suggesting acute pain
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presence in contrast with the physiologic indicators of the NVPS-R. Currently, the available
research using CPOT and NVPS-R instruments includes participants from medical, cardiac and
trauma ICUs, and applying those results to other populations is difficult. More research is needed
to validate instruments for different populations, such as patients during the early postoperative
period. Our preliminary findings suggest that the CPOT, with the use of the vocalization
parameter, is a better acute pain indicator than the physiological parameters of the NVPS-R, but
additional studies are needed to confirm this finding.
The main recommendation for future research is to identify valid, reliable and consistent
measures of pain in non-verbal patients during the early postoperative period. Healthcare
providers need tools to guide acute pain assessment and treatment because of the current frequent
inadequate assessment in sedated patients. The decrease in physiologic responses to the acute
pain symptom experience, pain alleviation, early discharge and complete recovery of patients are
the main outcomes of the adequate symptom management. Improved communication between
patients and healthcare providers can be achieved through research in postoperative acute pain to
improve clinical protocols and include the acute pain phenomenon as a teaching priority for
healthcare providers.
As stated by the American Pain Society (2016), there is low quality evidence to
recommend a specific validated pain assessment instrument to track responses after
postoperative pain treatments and adjust plans individually. There is insufficient evidence to
guide recommendations in the immediate postoperative setting (Chou et al., 2016). We need to
be committed to conduct further studies to contribute to the assessment and treatment of those at
risk for suffering acute pain.
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Conclusion
Finally, after evaluation of the results, we suggest that the CPOT may be the better tool
to guide early actions in the management of acute pain to achieve better postoperative outcomes.
The CPOT shows that the vocalization indicator is the most consistent criterion presented in
PACU patients with acute pain over time. While this study’s results present an overall high
correlation between pain scores on both behavioral tools (CPOT and NVPS-R) in patients after
general anesthesia and abdomino-pelvic, gastrointestinal and gynecological surgeries, incidental
findings suggest that physiological indicators of NVPS-R in patients with acute pain are not
consistent in their results. The vital sign indicators included in the NVPS-R need to be
investigated further to determine their validity for assuring adequate pain assessment in
postoperative patients because our findings do not support their use exclusively.
This study is important because pain assessment is the best way to initiate the most
appropriate treatment to alleviate pain after surgery. Recent literature confirmed the research gap
in assessment of postoperative pain in nonverbal patients leading to the release of the first
guideline for the management of postoperative pain (APS, 2016). The APS expert panel
recommends that clinicians use a validated pain assessment instrument, but there is inadequate
evidence to guide recommendations about which specific non-verbal pain instrument to use.
The communication barrier between clinicians and non-verbal patients limits the appropriate
acute pain symptom assessment during the early postoperative period; however the use of
behavioral instruments can lead to better pain management.
Findings of this study provide evidence to support relationships between CPOT and
NVPS-R in certain behavioral pain indicators, including facial expressions, muscle tension, and
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body movements. Both instruments showed a strong correlation in their assessment of acute
pain in nonverbal sedated patients after general anesthesia during the early postoperative period.
However, it was found that the vital sign parameters of the NVPS-R are not consistent indicators.
On the other hand, the incidental finding that CPOT vocalization is a consistent indicator in
patients with significant pain deserves further investigation. The study findings contribute to
providing significant data needed to establish specific recommendations in the assessment of
pain in postoperative patients. The absence of studies to support and recommend a specific
behavioral pain instrument for nonverbal sedated postoperative adults in post anesthesia care
units leads nurses to misuse existing instruments, undertreat patients’ pain, and increase the gap
in the standard of care for pain assessment and management. Patients who are evaluated early to
identify the presence of acute pain and have early management have a lower rate of
postoperative complications due to the stress response (Barr et al., 2013).
The 2010 Patient Protection and Affordable Care Act (PPACA), 111 Law, Section 4305,
required the Human Health Secretary (HHS) to establish an agreement with the Institute of
Medicine (IOM) for activities directed to increase the recognition of pain as a significant public
health problem. The 2011 IOM report prompted the HHS to release a National Pain Strategy in
2016, which focused support on research to identify and reduce barriers to appropriate care,
adequacy of assessment, diagnosis, treatment, and management of acute pain in all conditions in
which it could be present. This mandate forces us to focus our own efforts as researchers to
address pain symptom concerns.
The goal of nursing and anesthesia professionals is to contribute to the treatment of
patients suffering from pain and to help in the process of early recovery of patients after
anesthesia and surgery. For effective pain assessment and management we need to assess pain in
89

a systematic way. Pain assessment should be measured at regularly established intervals during
the early postoperative period. As previously stated, assessment is the basis for adequate pain
treatment and the achievement of positive postoperative outcomes.
As clinicians, we believe that vital signs alone are not good criteria to define pain
presence during early pain assessment for all patients. PACU nurses need to agree on a set of
measures used to assess pain that should be used to assess sedated patient’s pain, in order to
provide the best care. To improve the quality of pain assessment and management, healthcare
providers must consistently use a reliable, validated instrument.
Institutions where surgeries are performed need to standardize and provide clear policies
and procedures for effective postoperative pain assessment and management. Follow-up pain
assessments provide an objective mechanism to decrease the number of patients who experience
pain and decrease complications due to inadequate assessment and management of pain in daily
practice. Healthcare providers are patient advocates and a clear vision in providing the most
effective pain assessment and management will contribute to reducing the worldwide problem of
undertreatment of acute pain.
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APPENDIX A
PERMISSION TO USE INSTRUMENTS
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Neither party shall be under any liability for any loss or for any failure to perform any obligation hereunder due to causes beyond their
control including, but without limitation, industrial disputes of whatever nature, acts of God, hostilities, force majeure or any
circumstances which they could not reasonably foresee and provide against.
The Agreement will be governed by the Canadian laws.
To complete if the CPOT is used for a research purpose :
Validation of any newly developed tool like the CPOT is a long process. Any research using the CPOT could include interesting data
which may result in some modifications in the CPOT in order to improve its content for better patient’s pain assessment in the nonverbal critically ill population. By sharing your research data, the CPOT could be revised or modified, and the validation could be
enhanced.
x Yes, I accept to share my data with the author of the CPOT.
No, I refuse to share my data with the author of the CPOT.
By accepting to share your data with reference to the education/research and fair dealing provisions of copyright legislation, you agree
that the author Céline Gélinas or American Association of Critical-Care Nurses has the right to publicly identify the source of the data in
any published document.
Refusing to share your data doesn’t interfere with the permission for you to use the CPOT as agreed above.

IN WITNESS WHEREOF, the parties hereto, who are authorised signatories, have executed this Agreement:
__01__ / _03___ / _2015___ (month-day-year)
Date

___________Sherily

Pereira_ (electronic sign)___

(signature)
Céline Gélinas, RN, PhD
Assistant Professor
School of Nursing
McGill University
3506, University Street, Wilson Hall, Room 420
Montreal, Quebec
H3A 2A7, Canada
Tel: (514) 398-6157
Fax: (514) 398-8455
celine.gelinas@mcgill.ca

Name : Sherily Pereira______
Address
_____________________________________

PMB #72 Box 70344 San Juan,
Puerto Rico, 00936
_______________________________
_______________________________
_______________________________
Email
________________________________

1
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APPENDIX B
LETTER OF AUTHORIZATION FROM THE ASEM SETTING
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APPENDIX C
CRITICAL CARE PAIN OBSERVATION TOOL (CPOT)
Facial expressions

Relaxed, neutral

Tense

Grimacing

No muscle tension
observed

Presence of frowning,
brow lowering, orbit
tightening and levator
contraction or any
other change (e.g.
opening eyes or tearing
during nociceptive
procedures)

All previous facial
movements plus eyelid
tightly closed (the
patient may present
with mouth open or
biting the endotracheal
tube)

Absence of movements
or normal position.
Does not move at all
(doesn’t necessarily
mean absence of pain)
or normal position
(movements not aimed
toward the pain site or
not made for the
purpose of protection)

Protection

Restlessness/Agitation

Slow, cautious
movements, touching or
rubbing the pain site,
seeking attention
through movements

Pulling tube, attempting
to sit up, moving
limbs/thrashing, not
following commands,
striking at staff, trying
to climb out of bed

Talking in normal
tone or no sound

Sighing, moaning

Crying out, sobbing

0-2

Muscle tension

Relaxed

Tense, rigid

Very tense or rigid

0-2

Evaluation by passive
flexion and extension of
upper limbs when
patient is at rest or
evaluation when patient
is being turned

No resistance to passive
movements

Resistance to passive
movements

Strong resistance to
passive movements or
incapacity to complete
them

Sub total score

0

1

2

Body movements

Compliance with the
ventilator (intubated
patients)

0-2

0-2

OR
Vocalization (extubated
patients)

Total score: 0 -8

Adapted from Gélinas, C., Fillion, L., Puntillo, K. A., Viens, C., & Fortier, M. (2006). Validation of the Critical-Care Pain Observation Tool in adult patients. American Journal of

Critical Care, 15 (4), 420-427.

Key: 0-2 points = No pain ≥ 3-8 = significant pain
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APPENDIX D
NON-VERBAL PAIN SCALE REVISED (NVPS-R)

Categories

0

1

2

Face

No particular
expression or smile.

Occasional grimace,
tearing, frowning,
wrinkled forehead.

Frequent grimace,
tearing, frowning,
wrinkled forehead.

Activity

Lying quietly, normal
position.

Seeking attention
through movement or
slow, cautious
movement.

Restless, excessive
activity and/or
withdrawal reflexes.

Guarding

Lying quietly, no
positioning of hands
over areas of body.

Splinting areas of the
body, tense.

Rigid, stiff.

Physiologic I
(Vital signs)

Stable vital signs

Change over past 4
hours in any of the
following:

Change over past 4
hours in any of the
following:

* SBP > 20 mm HG. *
HR > 20/minute.

* SBP > 30 mm HG. *
HR > 25/minute.

RR > 10 above
baseline, or 5% SpO2
or mild asynchrony
with ventilator

RR > 20 above
baseline, or 10%
SpO2 or severe
asynchrony with
ventilator

Respiratory

Sub Total Score

Baseline RR/SpO2
Compliant with
ventilator

0

1

2

SBP= systolic blood pressure, HR= heart rate, RR= respiratory rate SpO2= pulse oximetry.
Instructions: Each of the five categories is scored from 0-2, which results in a total score between zero and
ten. Document total score by adding numbers from each of the five categories. Key: Scores of 0-2
indicate no pain, 3-10 pain. Sepsis, hypovolemia, hypoxia need to be excluded prior to
interventions.© Strong Memorial Hospital, University of Rochester Medical Center, 2004.Usedwithpermission

97

APPENDIX E
RICHMOND AGITATION AND SEDATION SCALE (RASS)
Score

Term

Description

+4

Combative

+3

Very agitated

+2

Agitated

+1

Restless

0

Alert and Calm

-1

Drowsy

-2

Light sedation

-3
-4

Moderate
sedation
Deep sedation

-5

Unarousable

Overtly combative, violent,
immediate danger to staff
Pulls or removes tube(s) or
catheter(s); aggressive
Frequent non-purposeful
movement, fights ventilator
Anxious but movements not
aggressive vigorous

Not fully alert, but has
sustained awakening(eye
opening/eye contact) to voice
(> 10 seconds)
Briefly awakens with eye
contact to voice (< seconds)
Movement or eye opening to
voice (but no eye contact)
No response to voice, but
movement or eye opening to
physical stimulation
No response to voice or
physical stimulation

Key: If RASS is -5, stop and Reassess patient at 15 minutes later.
If RASS is above -4 to -2 proceed to CPOT and NVPS-R Pain Assessment
*Sessler, et al. AJRCCM 2002; 166:1338-1344
*Ely,et al. JAMA 2003; 289:2983-2991.
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APPENDIX F
CONSENT FORMS (ENGLISH AND SPANISH VERSION) AND REQUEST FOR
WAIVER OF AUTHORIZATION
Consent Form for Participation in a Research Study (ENGLISH VERSION)
University of Massachusetts Amherst

Researcher(s): Annette Wysocki, PhD- Professor, College of Nursing, UMASS-Amherst, and
Sherily Pereira Morales RN, MSN- 5th year doctoral student, College of Nursing, University of
Massachusetts (UMASS), Amherst
Study Title: Acute Pain Symptom Assessment and Management in Nonverbal Puerto Rican
Patients in the Early Postoperative Period

1. WHAT IS THIS FORM?
This form is called a Consent Form. It will give you information about the study so you can
make an informed decision about participation in this research.
This consent form will give you the information you will need to understand why this study is
being done and why you are being invited to participate. It will also describe what you will need
to do to participate and any known risks, inconveniences or discomforts that you may have while
participating. We encourage you to take some time to think this over and ask questions now and
at any other time. If you decide to participate, you will be asked to sign this form and you will be
given a copy for your records.
2. WHO IS ELIGIBLE TO PARTICIPATE?
Subjects must be at least 21 years old and older to participate. You can take part in this study if
you are undergoing to an abdominal, pelvic or gastrointestinal surgery; and be under sedation
effects after surgery.
3. WHAT IS THE PURPOSE OF THIS STUDY?
Acute pain is a phenomenon commonly experienced by patients after surgery in post anesthesia
care units (PACU). The purpose of this research study is to compare the use of two behavioral
acute pain assessment instruments during the early postoperative period for non-verbal sedated
patients to enhance early pain assessment and management.
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4. WHERE WILL THE STUDY TAKE PLACE AND HOW LONG WILL IT LAST?
This study will take place at Post Anesthesia Care Unit (PACU) of the Medical Center of Puerto
Rico (ASEM). You will participate in this study for a period of two hours in the early
postoperative period in PACU.
There will be no communication with you after the discharge from PACU, nor in the future.

5. WHAT WILL I BE ASKED TO DO?
If you agree to take part in this study, you will not be prompted to do anything.
Data from this study will be obtained in two ways. Some information will be obtained directly
from your medical record. Further information will be obtained directly using assessment
instruments. The researcher estimates acute pain with the application of two observation
instruments for the assessment of pain behaviors. The evaluation of acute pain will be held on
arrival in the PACU, then every 15 minutes until complete one (1) hour and finally every 30
minutes to complete one (1) hour.
Major inclusion criteria include; consent for abdomino-pelvic, gynecologic, or gastrointestinal
surgery, which cannot verbalize or indicate pain using a traditional verbal scale such as the
numeric rating scale (NRS) upon his arrival in the PACU.
Exclusion criteria includes; patients able to self-report of pain, with an initial sedation scale score
that show an awake state.
Patients with a chronic cognitive impairment as dementia, alzheimer’s disease, or neurological
weaknesses (paraplegia, quadriplegia, amputation of upper limbs or stroke).
6. WHAT ARE MY BENEFITS OF BEING IN THIS STUDY?
You may not directly benefit from this research. Your pain after procedure may improve as a
result of your participation in this study. However, there is no guarantee of this.

We hope that the information from this research may lead to a better assessment and
management of acute pain in the future.
7. WHAT ARE MY RISKS OF BEING IN THIS STUDY?
We hope that the information from this research may lead to a best estimate and management of
acute pain in the future.
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This research involves traditional nursing care procedures. Risk or physical, emotional or social
discomfort are not anticipated by the assessment of acute pain with observation instruments.
We believe that there are no known risks associated with this research study, however, a possible
inconvenient that can happen is the time takes to complete study.
8. HOW WILL MY PERSONAL INFORMATION BE PROTECTED?
If you decide to participate in this study, the researchers will obtain personal information about
you. This may include information that could identify you and includes: birth date, admission
date, discharge date, and demographic data. The researchers can also get your health
information, including your medical record data, diagnosis, vital signs, surgery, and medications
administered.
The researchers may give information about you and your health, to:
• University of Massachusetts, Office for the protection of human subjects in research- HRPO
(IRB)
• The University of Puerto Rico, Medical Sciences Campus, Institutional Review Board -(UPR
MSC IRB)
To protect the confidentiality of your information in the records of the study, the following
procedures shall be used:
Information about you and your health that could identify you will be protected through the
assignment of a case number. The researchers will keep all records of study, including codes to
your data, to a file locked in her office. The records shall be protected according to the HIPAA
regulations. A master key that links names and codes will remain a separate and safe place. The
master key will be destroyed three (3) years after the end of the study.
Electronic files (REDCAP database, spreadsheets), containing personally identifiable
information will be protected with a password. Any computer that host files will also have
protection by password to prevent access by unauthorized users. Only the researchers will have
access to passwords. At the conclusion of this study, researchers will publish their findings. The
information will be presented in summary and you will be not identified in publications or
presentations.

The information can be reviewed by the University of Massachusetts - Amherst, Human
Research Protection Office (HRPO) and/or the institutional review board of the Medical
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Sciences Campus UPR, (IRB RCM UPR). It's a group of people who carried out an independent
review of the investigation as required by the regulations. In addition, the researcher will review
information with her dissertation Committee members at the University of MassachusettsAmherst. But the information provided will be confidential.

If you cancel this authorization, the investigator will not use or disclose your personal
information health authorization for this study, unless you need to use or disclose your personal
health information part to preserve the scientific integrity of the study. Researchers may use
submitted information before you cancel this authorization.

Authorization for use and disclosure for research purposes protected health information is
completely voluntary. However, if you do not sign this document you cannot participate in this
study. If this authorization is cancelled in the future, you will continue to not participate in this
study.
9. WHAT IF I HAVE QUESTIONS?
Take as long as you like before you make a decision. We will be happy to answer any question you
have about this study. If you have further questions about this project or if you have a researchrelated problem, you may contact the researcher(s), Sherily Pereira at (787) 234-5643 or
sherily@nursing.umass.edu or sherily.pereira@upr.edu.
If you have any questions concerning your rights as a research subject, you may contact the
University of Massachusetts Amherst Human Research Protection Office (HRPO) at (413) 5453428 or humansubjects@ora.umass.edu.
11. CAN I STOP BEING IN THE STUDY?
Your participation is voluntary, and you do not have to be in this study if you do not want. If you
agree to be in the study, but later change your mind, you may drop out at any time. There are no
penalties or consequences of any kind if you decide that you do not want to participate.
You may cancel this authorization at any time by sending a written notice to the investigator at
the following address:
Sherily Pereira Morales
University of Puerto Rico
Medical Sciences Campus
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School of Nursing
PO Box 365067
San Juan, Puerto Rico 00936

or by email at sherily@nursing.umass.edu or sherily.pereira@upr.edu

12.WHAT IF I AM INJURED?
The University of Massachusetts does not have a program for compensating subjects for injury
or complications related to human subjects research, but the study personnel will assist you in
getting treatment.

13. SUBJECT STATEMENT OF VOLUNTARY CONSENT
When signing this form I am agreeing to voluntarily enter this study. I have had a chance to read
this consent form, and it was explained to me in a language which I use and understand. I have
had the opportunity to ask questions and have received satisfactory answers. I understand that I
can withdraw at any time. A copy of this signed Informed Consent Form has been given to me.

________________________

____________________

__________

Participant Signature:

Print Name:

Date:

By signing below I indicate that I has read and consenting to having the researchers obtain my
personal health information. My personal health information will be obtained from the medical
record.

________________________

____________________

__________

Participant Signature:

Print Name:

Date:

By signing below I indicate that the participant has read and, to the best of my knowledge,
understands the details contained in this document and has been given a copy.
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_________________________

____________________

__________

Signature of Person

Print Name:

Date:

Obtaining Consent

Created by spereira/8/13/15
Rev.spereira/8/27/15
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FORMULARIO DE CONSENTIMIENTO PARA PARTICIPACION EN UN ESTUDIO
DE INVESTIGACION Y AUTORIZACIÓN PARA USO Y DIVULGACIÓN DE
INFORMACIÓN DE SALUD (SPANISH VERSION)
Universidad de Massachusetts-Amherst y Universidad de Puerto Rico- Recinto de Ciencias
Médicas

Investigador(as): Carmen Mabel Arroyo, PhD- Profesora, Universidad de Puerto Rico, Recinto
de Ciencias Médicas, Escuela de Enfermería y a Sherily Pereira Morales RN, MSN- 5to año
estudiante doctoral, Escuela de Enfermería, Universidad de Massachusetts- Amherst (UMASS)
Título del Estudio: Estimado y Manejo de Síntomas de Dolor Agudo en Pacientes
Puertorriqueños que no verbalizan en el Período Postoperatorio Temprano.
NÚMERO DE PROTOCOLO:
Patrocinador del Estudio: Ninguno

1. ¿Que es este formulario?

Usted está invitado para participar en un estudio de investigación. Este formulario de
consentimiento le proveerá a usted la información acerca del estudio para que asi pueda hacer
una decisión informada sobre su participación. Antes de que usted decida participar en el estudio,
por favor lea este formulario cuidadosamente.
Este formulario de consentimiento le dará la información necesaria para entender porqué se hace
este estudio y por qué usted está siendo invitado a participar. También se describe lo que tendrá
que hacer para participar y los riesgos conocidos, inconvenientes o molestias que pueda tener
durante su participación. Le agradecemos tome algún tiempo para pensar y realizar preguntas en
este momento y/o en cualquier otro momento para asegurarse que entienda los procedimientos
del estudio, incluyendo riesgos y beneficios.
Si usted decide participar, se le pedirá que firme este formulario y se le dará una copia para su
archivo.

2. ¿QUIÉN ES ELEGIBLE PARA PARTICIPAR?
Pare ser elegible para participar usted debe tener 21 años o más. Usted puede participar de este
estudio si está programado para realizarse una cirugía abdominal, pélvica o gastrointestinal; y se
espera que los efectos de la sedación continúen en el periodo postoperatorio temprano (0-2
horas), después de la cirugía y que no pueda verbalizar o indicar dolor utilizando una escala
verbal tradicional tales como la escala de calificación numérica (NRS) a su llegada a la Unidad
de Cuidado Post Anestesia (PACU).
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Usted no sera elegible si está alerta y es capaz de indicar verbalmente la intensidad de dolor
agudo, con una escala de sedación inicial que indique que está alerta.
Usted no puede participar además si tiene un diagnóstico previo de crónico deterioro cognitivo
crónico como por ejemplo demencia o Alzheimer o debilidad neurológica (paraplejia, tetraplejia,
amputaciones de miembros superiores o accidente cerebrovascular).

3. ¿Cuál es el propósito de este estudio?

El dolor agudo es un fenómeno comúnmente experimentado por pacientes luego de cirugía en
unidades de cuidado post anestesia (PACU).El propósito de este estudio es comparar el uso de
dos herramientas de estimado de síntomas de dolor agudo durante el período postoperatorio
temprano para pacientes no verbales y dentro de niveles de sedación.

4. ¿DÓNDE SE LLEVARA A CABO EL ESTUDIO Y CUÁNTO DURARÁ?
Este estudio se llevará a cabo en la Unidad de Cuidado Post Anestesia (PACU) del Centro
Médico de Puerto Rico (ASEM). Usted participará en este estudio por un periodo de dos horas
mientras esté en PACU.
No habrá comunicación con usted después del alta de PACU, ni en el futuro.

5. ¿QUÉ SE LE SOLICITARÁ HACER?
Si usted acepta formar parte de este estudio se le solicitará permita al investigador
obtenga los datos de este estudio de dos maneras. Algunos datos se obtendrán directamente de su
expediente médico. Otros datos se obtendrán mediante la observación de conductas de dolor. El
investigador le realizará el estimado del dolor agudo postoperatorio utilizando dos escalas
diferentes que miden dolor mediante la observación de conductas. La observación del dolor
agudo con las escalas se realizarán en diferentes tiempos; a su llegada a PACU, luego cada 15
minutos hasta completar una (1) hora y finalmente cada 30 minutos hasta completar una (1) hora
adicional. El tiempo total de estimado de dolor son 2 horas.

6. ¿Cuáles son mis beneficios por participar en este estudio?

Usted no se beneficiará directamente por participar de esta investigación. Su dolor después del
procedimiento puede mejorar como resultado de su participación en este estudio. Sin embargo,
no hay ninguna garantía de ello.
Esperamos que la información de esta investigación puede conducir a un mejor estimado y
manejo del dolor agudo en el futuro.
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7. COSTOS
No se le cobrará a su familiar, a usted o su compañía de seguros por participar en este estudio.
No hay ningún costo por participar en este estudio.
8. INCENTIVO PARA EL PARTICIPANTE
A usted no se le pagará por ser parte de este estudio.
9. ¿CUÁLES SON MIS RIESGOS AL PARTICIPAR EN ESTE ESTUDIO?
Esta investigación involucra procedimientos tradicionales de cuidado de enfermería. No se
anticipan riesgos ni molestias físicas, emocionales o sociales al realizarse el estimado de dolor
agudo con los instrumentos de observación.
Creemos que no existen riesgos conocidos asociados con este estudio de investigación; sin
embargo, un posible inconveniente puede ser el tiempo que tome el completar el estudio.
10. ¿CÓMO SE PROTEGE MI INFORMACIÓN PERSONAL?
Si usted elige participar en este estudio, la investigadora del estudio conseguirá información
personal sobre usted. Esta puede incluir información que puede identificarle y puede también
conseguir información sobre usted en el expediente clínico tales como: edad , sexo y número de
expediente médico, hora de alta de PACU ; e información de salud que se limitan a: estado físico
ASA , diagnósticos , los signos vitales , tipo y duración de la cirugía , la anestesia administrada ,
resultados de laboratorio , evaluaciones de dolor , presencia de dolor al momento del alta , los
medicamentos administrados y los efectos secundarios durante estadia en PACU.
Para proteger la confidencialidad de su información en los registros de estudio, se utilizarán los
siguientes procedimientos:
Información sobre usted y su salud que podría identificarle estarán protegidos mediante la
asignación de un número de caso. Los investigadores mantendrán todos los registros de estudio,
incluyendo los códigos a sus datos, en un archivo bajo llave en su oficina. Los registros serán
protegidos según las regulaciones HIPAA. Una clave maestra que vincula nombres y códigos se
mantendrá en un lugar separado y seguro. La clave maestra se destruirá a los tres (3) años
después del cierre del estudio.
Los archivos electrónicos (base de datos de REDCAP, hojas de cálculo), que contengan
información de identificación personal serán protegidos con una contraseña. Cualquier equipo
que almacene tales archivos también contará con protección por contraseña para evitar el acceso
a usuarios no autorizados. Sólo los investigadores tendrán acceso a las contraseñas. En la
conclusión de este estudio, los investigadores podrán publicar sus hallazgos en revistas
científicas o ser presentados en foros de investigación, pero la identidad de usted no será
divulgada. La información se presentará en resumen y usted no será identificado en
publicaciones o presentaciones.
La información puede ser revisada por la Universidad de Massachusetts - Amherst, Oficina de
Protección de la Investigación Humana (HRPO) y / o la Junta de Revisión Institucional del
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Recinto de Ciencias Médicas de la UPR, (IRB RCM UPR). Se trata de un grupo de personas que
realizan una revisión independiente de la investigación según lo requerido por las regulaciones.
Además, los miembros del Comité de disertación del investigador en la Universidad de
Massachusetts-Amherst revisarán la información. Sin embargo la información provista será
confidencial.
Si cancela esta autorización, el investigador principal no usará o divulgará su información
personal de salud con la autorización para este estudio, a menos que necesite usar o divulgar
parte de su información de salud personal para preservar la integridad científica del estudio. Los
investigadores pueden usar información presentada antes de cancelar esta autorización.
La autorización para el uso y divulgación de información de salud protegida para propósitos de
investigación es totalmente voluntaria. Sin embargo, si usted no firma este documento no podrá
participar en este estudio. Si en el futuro se cancela esta autorización, usted no continuará
participando en este estudio.

11. ¿QUÉ SUCEDE SI TENGO PREGUNTAS?
Tome el tiempo que usted necesite antes de hacer una decisión. Estaremos disponibles de
responder cualquier pregunta que usted tenga acerca de este estudio o sobre su participación en
el mismo, o si piensa que ha sufrido alguna lesión asociada al estudio, usted puede contactar a la
investigadora principal: Dra. Carmen Arroyo al 787-758-2525 Ext. 2115 ó a Sherily Pereira
Morales al (787)758-2525 Ext. 2115
Si usted tiene alguna pregunta sobre los derechos como participante del estudio, usted puede
contactar a la:
Oficina de Protección de Participantes Humanos en Investigación
Teléfono (787) 758-2525 Exts. 2510 ó 2515
E-mail: opphi.rcm@upr.edu
12. ¿PUEDO DEJAR EL ESTUDIO?
Su participación es voluntaria, y usted no tiene que participar en este estudio si asi lo desea. Si
acepta participar en el estudio, pero más tarde cambia de opinión, se puede retirar en cualquier
momento. No existen sanciones ni consecuencias de ningún tipo si usted decide no participar.
Usted puede cancelar esta autorización en cualquier momento enviando una notificación por
escrito a las investigadoras a una de las siguientes direcciones:
Investigadora Principal:
Dra. Carmen Mabel Arroyo
Universidad de Puerto Rico
Recinto de Ciencias Médicas
Escuela de Enfermería
Departamento Graduado
PO Box 365067
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San Juan, Puerto Rico 00936
ó por correo electrónico a carmen.arroyo1@upr.edu
Sherily Pereira Morales
Universidad de Puerto Rico
Recinto de Ciencias Médicas
PO Box 365067
San Juan, Puerto Rico 00936
ó por correo electrónico a sherily@nursing.umass.edu ó sherily.pereira@upr.edu
13 ¿QUÉ PASA SI ME LESIONO?
En el caso de lesión física o mental, como resultado de este estudio de investigación, usted
recibirá tratamiento médico libre de costo en el Hospital Universitario o cualquier otro hospital
designado por el Rector del Recinto de Ciencias Médicas de la Universidad de Puerto Rico. La
Universidad de Puerto Rico no prevé ofrecerle ninguna otra forma de compensación o
remuneración directamente a usted. Sin embargo, por firmar este formulario de consentimiento,
usted no renuncia a ningún derecho legal que pudiera tener.
14. DECLARACIÓN DE CONSENTIMIENTO VOLUNTARIO
Al firmar este formulario estoy de acuerdo en entrar voluntariamente en este estudio. He tenido
oportunidad de leer este formulario de consentimiento, y me fue explicado en el lenguaje que
utilizo y entiendo. He tenido la oportunidad de hacer preguntas y haber recibido respuestas
satisfactorias. Entiendo que me puedo retirar del estudio en cualquier momento.
Autorizo el uso y la divulgación de mi información de salud a las entidades antes mencionadas
en este consentimiento para los propósitos descritos anteriormente. Al firmar esta hoja de
consentimiento, no he renunciado a ninguno de mis derechos legales. No firme este
consentimiento a menos que haya tenido la oportunidad de hacer preguntas y recibir
contestaciones satisfactorias para todas sus preguntas.
Si usted firma aceptando participar en este estudio, recibirá una copia firmada y fechada de este
documento para usted, con el sello de aprobación del IRB en cada hoja.
________________________
Firma del Participante:

____________________
Nombre en letra de molde:

____________
Fecha:

La firma en el siguiente espacio indica que el participante ha leído y en mi conocimiento,
entiende la información contenida en este documento y se le ha entregado una copia.

_________________________
Firma de la persona
que obtiene el consentimiento

____________________
Nombre en letra de molde:
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__________
Fecha:
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APPENDIX G
SOCIO-DEMOGRAPHIC INSTRUMENT
Instructions: Fill the blanks with an (X) and provide the number in the space provided.
1. Age: ___years
2. Weight: ______kgs
3. Race: ____Black _____Hispanic ______White
4. Education: Primary_______ Secondary_______ Post Secondary________
Bachelor degree____ Master degree_____ Doctoral degree_______
5. Diagnoses: _________________________
6. Type of Surgery planned: _______________________
7. General Anesthesia proposed:_____________________________________
8. Pain presence: _____yes ____no. If yes, NRS score____.
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APPENDIX H
DATA COLLECTION PLAN

Activity

Estimated Time

In advance
Identify potential patients by
consulting with gynecologist
personnel, and review medical
history and pre-anesthesia form
for inclusion criteria

10 minutes

Pre surgery visit
7-0 days before surgery
Get patient verbal/written
consent

10 minutes

Day of surgery
Obtain patient demographics and
other data from chart
Intervention

5 minutes
120 minutes

Assess and rate acute pain during
the early post-operative period
using CPOT and NVPS-R,
immediate arrival at 0 minute to
2 hours after arrival to PACU
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APPENDIX I
PROJECTED TIMETABLE FOR DATA COLLECTION AND DATA ANALYSIS

One month

Three months

Obtain Human Subjects
Enroll sample patients.
Committee approval from
Collect data and enter into
UPR-MSC and UMASS
database.
IRB’s.
Develop data collection forms.
Construct database.

Two months

Perform data analysis.
Write dissertation.

UPR, MSC, University of Puerto Rico, Medical Sciences Campus; UMASS, University of Massachusetts-Amherst
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APPENDIX J
PROCEDURES TO RECRUITMENT, ENROLLMENT, AND DATA MANAGEMENT

+
AT CLI NI C
Inclusion
and
exclusion
cr iter ia

SURGERY DAY

At PACU

Sociodem ographic
data

M easure RASS
(-1 and m ore
exclude from
the study)
even
patients

odd
patients

met

No

Exclude
patient

Yes

Consent to
par ticipate
in the
study?

No

Yes
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CPOT at ar rival

NVPS at arr ival

NVPS at ar rival

CPOT at ar rival

CPOT at 15 m in

NVPS at 15 m in

NVPS at 15 m in

CPOT at 15 m in

CPOT at 30 m in

NVPS at 30 m in

NVPS at 30 m in

CPOT at 30 m in

CPOT at 45 m in

NVPS at 45 m in

NVPS at 45 m in

CPOT at 45 m in

CPOT at 60 m in

NVPS at 60 m in

NVPS at 60 m in

CPOT at 60 m in

CPOT at 90 m in

NVPS at 90 m in

NVPS at 90 m in

CPOT at 90 m in

CPOT at 120 m in

CPOT at 120 m in

NVPS at 120 m in

NVPS at 120 m in

APPENDIX K
SCREENING AND ELIGIBILITY DETERMINATION

SCREENING AND ELIGIBILITY DETERMINATION
Acute Pain Symptom Assessment and Management in Nonverbal Puerto Rican Patients at Early
Postoperative Period

Date:
Candidate #:
Inclusion Criteria:
Pre-operative
o Age >21
o
o Able to give informed consent.
o
o Consenting abdominal, pelvic or gastrointestinal surgery
o
Screening at PACU:
o RASS = -4 to -2 (deep, moderate and light sedation) at PACU
o Yes (enrolled patient)
o No (exclude patient)
o
Exclusion Criteria:
o Patients with a previous diagnosis of chronic cognitive impairment (Dementia,
Alzheimer) or neurologic impairment
o Non GETA
PACU

o o o o o o o o o o o o o o o o o o o o o o o o
o Patient able to self -report acute pain, with an initial sedation scale (RASS) = -1, and 0 to 4.

Reason to reject to be part of the study: _____________________________________________

Consent to participate: ________Yes, _______No
Patient ID Code:______________

‘
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APPENDIX M
TABLE OF ASSESSMENT OF ADEQUACY OF RANDOMIZATION
Assessment of Adequacy of Randomization
Characteristics
CPOT n=20
n (%)
mean ± SD

NVPS-R n=20
n (%)
mean ± SD

P value

51.2 ± 17.0

47.3 ± 17.4

0.5d

16 (55.2)

13 (44.8)

4 (36.4)

7 (63.6)

0.5a

84.0 ± 22.8

75.6 ± 34.9

0.1d

Uterine Myoma
Yes
No

3.0 (60.0)
17.0 (48.6)

2.0 (40.0)
18.0 (51.4)

0.6a

Hernia
Yes
No

1.0 (20.0)
19.0 (54.3)

4.0 (80.0)
16.0 (45.7)

0.3a

Gynecologic Carcinoma
Yes
No

9.0 (90.0)
11.0 (36.7)

1.0 (10.0)
19.0 (63.3)

0.008a*

Colon Carcinoma
Yes
No

1.0 (16.7)
19.0 (55.9)

5.0 (83.3)
15.0 (44.1)

0.2a

Ureter Carcinoma
Yes
No

0.0 (0.0)
20.0 (51.2)

1.0 (100.0)
19.0 (49.7)

0.5a

Others
Yes
No

7.0 (66.7)
13.0 (48.1)

6.0 (33.3)
14.0 (51.9)

Healthy Patient

3.0 (75.0)

1.0 (25.0)

Mild Systemic

11.0 (40.7)

16.0 (59.2)

5.0 (62.5)

3.0 (37.5)

Age in years
Gender
Female
Male
Weight in kg
Primary diagnosis

ASA Physical Status Classification
System

Severe Systemic

120

0.4a

Incapacitating Systemic

1.0 (100.0)

0.0 (0.0)

608.7 ± 155.4

575.5 ± 130.8

0.7d

Fentanyl
Yes

20.0 (50.0)

20.0 (50.0)

Cannot be
assessed

Morphine
Yes
No

8.0 (38.1)
12.0 (63.2)

13.0 (61.9)
7.0 (36.8)

0.1b

Others
No

20.0 (50.0)

20.0 (50.0)

Cannot be
assessed

Total Anesthesia time (minutes)

Opioids

a

Fisher Exact
Pearson’s chi2
c T-Test
d Mann-Whitney
* p<0.05
b
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APPENDIX N
ASSOCIATION OF PAIN ASSESSMENT WITH RANDOMIZATION
Association of Pain Assessment with Randomization at Seven Occasions of follow-up (with
MEANS and SD)
Number, n

1st

2nd

P-Value

2.55 (1.85)
2.30 (1.45)
2.60 (1.60)
2.22 (1.52)
2.12 (1.58)
2.2 (1.66)
1.93 (2.02)

2.50 (2.31)
3.50 (1.85)
2.82 (1.88)
3.05 (1.90)
2.42 (2.04)
1.89 (1.41)
1.4 (1.43)

0.70
0.05*
0.78
0.11
0.58
0.62
0.63

2.50 (1.79)
2.30 (1.45)
2.50 (1.54)
2.17 (1.54)
1.82 (1.59)
2.07 (1.62)
1.86 (1.99)

2.25 (2.02)
2.83 (1.65)
2.47 (1.50)
2.90 (1.74)
2.37 (1.67)
2.17 (1.62)
1.60 (1.35)

0.51
0.32
0.89
0.18
0.24
0.87
0.98

Means (SD)
CPOT, minutes
0
15
30
45
60
90
120
NVPS-R, minutes
0
15
30
45
60
90
120
* P-value<0.05
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